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This study is dedicated to all patients who desire to be active participants in their
healthcare and to those patients who are not aware that they can participate in their
treatment decisions. I hope the results from this research study and future patient centered
care research takes us closer to routinely practicing shared decision-making in every
clinical encounter.
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ABSTRACT
Shared decision making (SDM) is a collaborative decision-making style where the
patient and the physician are involved in the clinical decision-making process. The goal
of this dissertation project was to examine the relationship between the patient portal of
an electronic health record (EHR) and SDM.
The SDM process has three main components: information sharing, deliberation
and decision making. Patients participate in SDM at varying levels: some patients may
prefer to share information and deliberate but leave the final decision making to the
provider while others prefer to participate in all the three components of SDM. The
patient portal of an EHR provides a platform where patients can access their health
information and maintain continuous interaction with their healthcare provider beyond
the office visit. Additionally, the patient portal helps the patient overcome the issue of
time constraints during the in-office visit as it provides a platform to communicate with
their providers beyond the scheduled time allocated to the patient during their visit.
We utilized data from the Health Information National Trends Survey (HINTS)
which is administered by the National Cancer Institute and ran a regression analysis to
examine the relationship between the patient portal of an EHR and SDM. The
relationship between the patient portal and SDM was examined across the three
components of SDM across the total population and for patients with chronic disease or a
preference sensitive condition. To measure SDM, we used a top box scoring approach.
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Our study did not show a significant relationship between the patient portal and
SDM. However, the relationship between SDM and immigrant status and level of
education were significant. In conclusion, this project showed that participation in SDM
goes beyond knowledge, which the portal provides, to empowering the patient to
participate in their care.
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CHAPTER 1
INTRODUCTION
At some point in any clinical encounter, a treatment decision would have to be
made by either the physician, patient or jointly by the physician and patient. The
complexity of the decision-making process increases when there are multiple viable
treatment options. The treatment options for some health conditions, like breast and
prostate cancers, range from non-invasive medications to surgery or no treatment [1], [2].
Each treatment option carries risks, benefits, and uncertainty, thus creating a dilemma on
the most appropriate option for the patient especially when the patient has multiple comorbidities [1], [2].
Clinical decisions usually are made either by the health care provider, patient,
proxy or collaboratively by the patient or/and proxy and the healthcare provider [3], [4].
Shared decision-making (SDM) refers to a clinical decision making process that actively
involves the patient [3], [4]. Increased patient reported satisfaction, and other benefits
derived from the SDM communication style can be ascribed to the inclusive nature of this
treatment decision making model where the patient is related with as a contributing
‘member’ of his health team and the treatment option chosen usually reflects the patient’s
preference based on his or her unique circumstance[5]–[9]. More specifically, Coulter et
al report that patients’ who are actively involved in their clinical decision making have
better outcomes compared to passive patients [10]. Patients who participate in SDM have
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reported less decisional regret and an overall increased satisfaction with the health
system especially in the long term [5]–[9].
SDM is not the only form of physician-patient interaction. Other common forms
of treatment decision-making include:1) the paternalistic and 2) informed decision
making [11]. Previously, the paternalistic model was the most predominant clinical
decision making model [12]–[15]. It is a one-way process where the physician assumes
an authoritative role, that entails him or her deliberating and deciding on the best
treatment option without consulting the patient for their preferred treatment option.
The paternalistic form of treatment decision making began to lose its popularity in
the early 1980’s after the President’s Commission for the Study of Ethical Problems in
Medicine and Biomedical and Behavioral Research carried out a review on the ethics
surrounding clinical decision making [16]. The review highlighted the injustice of the
power imbalance in the physician-patient relationship with the patient subservient to the
physician. The report stated that it is imperative for health care to be aligned to a patient’s
value system and treatment preference. Previously, only affluent patients were offered the
‘luxury’ of communicating their treatment preference to their physician. This review
called to attention the unbalanced power dynamics in the physician-patient relationship in
the US, and since then there has been a gradual tilt of the relationship from the
authoritative to a more patient centered care approach. Additionally, increasing patient
awareness, more focus on patient autonomy and fear of litigation further reduced the
routine practice of the paternalistic clinical decision-making communication style.
However, when the best treatment option is clear based on clinical guidelines or a
procedure is life-saving, a paternalistic approach may still be taken (with informed
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consent). In such circumstances the paternalistic is considered acceptable because there
are no treatment options to deliberate and choose from [12] and the patient preference for
treatment and the providers are usually the same [12]. Although an informed consent
(approval for a procedure or treatment to be performed on a patient) is obtained in the
latter scenario, the informed consent is different from the informed decision model [12].
The informed decision model is at the other end of the spectrum from the
paternalistic model [12]–[15]. This model transfers all the decision making to the patient,
and the role of the physician is to inform the patient of his or her treatment options [9]–
[12]. In this context, the treatment decision is left to the patient and the physician’s role
can be described as a competent technical expert in this setting [15]. Although this model
actively involves the patient in the decision making process, the experience and expertise
of the physician may not be put to its best use [17]. It is assumed that the knowledge and
experience that the physician gained over years of training and practice can be passed on
to the patient in a short amount of time. This treatment decision communication style is
infeasible because of the knowledge gap and most treatment decisions need to be made in
a short period of time. Thus, the main challenge with this communication style is how to
get the patient to the level where they are knowledgeable enough to make the same
decision that the physician would have made if he was the patient and had the same
preferences and values.
The most advocated approach for making treatment decisions is shared decision
making [12]–[15]. The SDM approach falls in the middle of the spectrum from the
paternalistic and informed consent models. It is a two-way directional flow of
information and collaborative decision making process between the patient and
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physician, involving other providers as well as friends and family members when
necessary [12]–[15],[18]. It is not uncommon for patients and their physicians to have
different treatment priorities. For instance, a physician’s goal may be to cure the patient’s
disease and prolong his or her life, but a patient’s priority may be just to live long enough
for an anniversary or be pain-free. Identifying the most appropriate option for the patient
may require reflection on how each available treatment option relates to the patient’s
short and long-term goals, personality, lifestyle, socio-economic status and a host of other
factors. Sometimes a patient may require more reflection time beyond the regular office
visit to come up with the most appropriate treatment option for him or her [19]. Thus,
platforms such as an electronic health record portal that offer communication and
information sharing channels between providers and patients is essential for a
collaborative treatment decision making approach. The patient’s portal offers a channel to
help bridge the gap between office visits, because patients can access their health
information outside of the clinical setting and establish an ongoing communication
channel with their health care providers beyond the office visit. In addition, the portal has
the potential to enrich standard clinical interaction between the patient and the doctor
because patients have more time to review their health information and reflect on their
treatment options prior to an office visit.
SDM can be practiced during any clinical encounter: primary care, specialist care,
acute and chronic care. In the primary care setting, active involvement of patients in their
clinical decisions has been shown to improve physiological outcomes in conditions like
diabetes and hypertension [20]. It has been shown that a majority of primary care patients
are uncertain about the best treatment option showing that SDM can be applied in almost
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every healthcare care settings [21], [22]. However, SDM has been recommended much
more highly for conditions where more than one viable treatment option exists [12]–[15].
Some studies have shown the highest utility of SDM in preference-sensitive conditions
like rheumatoid arthritis, angina, breast and prostate cancer which have more than one
viable treatment option and varied outcome with trade-offs between quality and length of
life [23], [24].
Even though there has been increased advocacy for patients’ involvement in their
clinical decision making process, not all patients and physicians are willing to participate
or routinely practice shared decision-making [25]. There is a group of patients who want
to participate in SDM to some extent: they want to be informed of their clinical
conditions and treatment options, be involved in the treatment deliberation process but
would prefer that the final treatment decision be made by the physician [25]–[28]. Some
patients prefer to be as equally involved as the physician throughout the treatment
decision process [25]–[28]. Another group of patients, majority of whom are usually
older, lower income, and less educated still prefer a paternalistic approach in medical
decision making [18], [19]. In these cases, some researchers believe that the onus of
initiating and practicing SDM lies with the physician because the balance of power tilts in
favor of the physician [31].
Physicians have identified several barriers that prevent them from routinely
practicing SDM. These barriers include time constraints, lack of applicability due to
patient characteristics, lack of applicability due to the clinical situation, and patient’s
preferred clinical decision making style [14], [31], [32]. These barriers have been called a
‘myth’ by some scholars and these scholars believe that with expert relational skills and
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flexibility, physicians can engage almost all patients in the shared decision making
process despite the perceived barriers [33].
As seen in Figure 1.1, the first component in the SDM process is information
sharing between physicians and patients. The physician shares technical information
based on his medical training and expertise while the patients provides information on his
treatment priorities which may be based on previous experiences, lifestyle, personality
and host of other factors. After information sharing, next is the deliberation component
where the patient and provider discuss the treatment options and the most appropriate for
the patient. The last component of the clinical decision making process is deciding on the
treatment option to be implemented[5], [8].

Information
Sharing

Deliberation

Decision
making

Figure 1.1: Components of the Shared Decision-Making Process
There are several ways to stimulate patients to be involved in the SDM process
shown above, one of them is the Personal Health Record (PHR). The PHR contains
details of the patient’s health records over time and in some cases provide a convenient
means for providers and patients to communicate and share medical information
depending on the type of PHR system [34], [35]. More recently, majority of healthcare
providers in the US utilize an Electronic Health Record (EHR) system to document
details of the clinical encounter such as notes, diagnostic test orders and results, and other
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pertinent clinical information in a secure computerized system which can be shared with
other providers and patients when required [36], [37].

Most EHRs have tethered patient portals from which the patient can access their
health records electronically[35]. The tethered patient portal is an extension of the
provider’s electronic health records of the patient, offered to the patients so the patient
can remotely access their health records electronically[38]. Providers are required to have
a patient portal as mandated by the Health Information Technology for Economic and
Clinical Health (HITECH) Act[39]. The HITECH Act was established in 2009 to
improve healthcare and health outcomes through the use of information technology[40],
[41]. Under this Act, eligible providers and hospitals are given financial incentives to
utilize EHR meaningfully with a total budget of 19.2 billion dollars [42], [43]. Certain
criteria were listed as part of the meaningful use requirement and provision of a patient
electronic health portal was one of them [35]. As at 2016, the adoption rate of patient
portal in the US was about 29% with the total Federal government reimbursement of 5
billion dollars to physicians for using EHR meaningfully and as of 2015, 479,000
providers had been reimbursed [43]–[45]. In 2017, about half the US population had
access to the portal but only 28% of the population were actively using the portal [46].

The portal provides the patient a means to access results from laboratory and
diagnostic tests, vital signs, problem list, medication allergies, medication list and for
hospitals, discharge summaries and procedures [43]. Patients can also reorder medication,
send secure messages to their providers and schedule appointments from this portal [43].
With these features, the patient portal acts a communication bridge between the patient
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and his or her physician beyond the time spent in the hospital or clinic, providing the
patient with a point of continuous contact with the health care system.

Significance of study

To the best of my knowledge, there is no study documented within the literature
that has explicitly described an association between the portal access, portal utilization,
and shared decision-making. Several studies have shown that the patient portal increases
patients knowledge about their health conditions; however, increased knowledge does not
necessarily translate to increased involvement in clinical decision making process [34],
[43], [47]–[49], [50].
A systematic review of 45 studies on SDM showed that providing more
information to the patient does not necessarily lead to shared decision making [31]. The
themes examined in the systematic review were related to how the health system is
organized and what happens during the clinical encounter [31]. None of the studies
examined demonstrate how access to the patient’s medical record and communicating
with the provider electronically influences SDM. The authors concluded that to fully
participate in the clinical decision making process, the patient should feel empowered and
invited to participate in the decision making process [31]. The patient portal of an EHR
has the potential to empower patients to participate in their treatment decision making
process. Providing the patient access to their health records and the opportunity to
communicate with their healthcare provider can be interpreted as an invitation to be more
involved in their treatment process because it bridges the gap between office visits. The
patient portal presents a means for the patient to review their health information and
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interact with their healthcare providers after their regular office visits. This study hopes to
close that knowledge gap and determine if access to the patient portal of an EHR goes
beyond just an increase in knowledge to actual participation in SDM.
A nationally representative sample was used to determine the extent to which
portal utilization is associated with the SDM process across multiple clinical conditions
[51]–[53]. Our study population was from Health Information National Trends Survey
(HINTS), a cross-sectional nationally representative sample of adults 18 years and above
[54]. The dataset contains information on cancer prevalence and treatment, nutrition,
health communication trends and practices, and health information technology access and
use [54]. More specifically, the data set contains survey questions that capture portal
utilization and measure the different components of SDM. HINTS surveys are mailed
questionnaires done periodically and the version used for this study (HINTS 5 Cycle 1)
was conducted between January and May 2017.
Aims of study
The main objective of this study is to examine the relationship between patients’
access to their EHR patient portal and their involvement in shared decision making. The
HINTS 5 Cycle 1 survey allows for investigation of the process of SDM because the
survey questions include measures of components of SDM: information sharing,
deliberation and decision making [54].
Aim 1: To describe the characteristics of patients who use the EHR patient portal
•

R1: What are the characteristics of the patients who use the EHR patient portal?

Aim 2: To determine the relationship between portal utilization and participation in SDM
9

•

R2: What is the association between portal utilization and SDM?

•

R3: What is the association between portal utilization and participation in SDM
among people with a chronic disease or preference sensitive condition?
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CHAPTER 2
LITERATURE REVIEW
In all relationships, communication skills are required to understand personal
values, preferences, and decisions. This is the same with the doctor-patient relationship.
For the doctor and patient to communicate about treatment options and preferences, they
both need good communication skills. Although both the patient and physician require
good communication skills, several ‘shared decision making’ researchers believe that the
physician is in the position to best initiate shared decision making [50], [55].
Evolution of medicine and the doctor patient relationship
To fully understand the current state of patient involvement in their clinical
decision-making process, we would have to review how medicine and the doctor-patient
relationship has evolved over the years. With social and cultural evolution, the doctorpatient relationship has undergone significant changes from the time of pre-Greek archaic
medicine to current day patient centered medical practice of the twenty-first century.
The earliest written documentation of medical records was in Mesopotamia,
present day Iraq, in 3,000 BC [56], [57]. At that time, the practice of medicine was
mainly spiritual, and physicians/healers had no biochemical basis for the origin of
diseases. Diseases were attributed to Gods, demons, evil spirits and witchcraft. Patients
relied entirely on physicians/healers who had supernatural powers to connect spiritually
to God than the ordinary person. This form of medical practice was also practiced in
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ancient Egypt, China and India between 1900 BC to 300 BC with a minimal inclusion of
science like pulse checking in China, medications in Egypt and surgeries in India.
Despite the subtle involvement of science, the physicians were more of spiritualists and
magicians and to the people, their knowledge transcended beyond normal human
comprehension. Most of the treatment offered were magic spells to drive out demons and
appease the Gods. So, the natural tendency was for the patient to comply with whatever
form of treatment the physician proffered. In such settings, there was no issue of patient’s
preference and/or questioning of treatment offered since the treatment regimen was
accepted as divine. The physician/healer was mainly a medium for conveying the
solution to the patient’s problem from the Gods to the patient. Thus neither the patient
nor the physician was in ‘charge’ of the decision making process [57]–[60]. The
physician was more of a medium to reach out to the spirit world. This form of clinical
decision making can be described as theistic [61].
In Greece during the time of the Roman Empire (from 500BC), the practice of
medicine became paternalistic. Medicine had become more scientific and the physician
had lost some of the mystic that surrounded medical practice [60]. The practice was
initially based on religion but progressively became more natural with the development
of rational explanations like imbalance in the fluids of the body as the origin of diseases
[60]. At this stage, the Hippocratic oath was established and the practice of medicine was
hinged on beneficence; with the doctor acting on the best interest of the patient [61], [62].
In this setting, the physician was like a parent who provides care for the patient with love
and kindness, providing the exact care to the patient that he would love to receive if the
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roles were reversed [56]. Just like well-behaved kids, a good patient would not question
the physician’s recommendation but follow orders, so they can be cured of their disease.
In the early medieval ages (early middle ages, between 500 AD and 1000 AD),
after the fall of the Roman empire, medical practice reverted back to religion, astrology,
superstition, invention, charlatanism, magic, and sorcery with very little input from
science [57], [61]–[65]. There was a decay in scientific knowledge and most disease
conditions were ascribed to be as a consequence of sin from God [57]. The church
became the predominant authority and non-clerical physicians were no longer in
existence [57]. Sicknesses were cured through exorcism, prayers and repentance from sin
[57]. For example, jaundice was treated by tying a live bat to the patients back and
stomach; poor eyesight was believed to be caused by excessive lust and was treated by
placing the skin of a fish’s bladder over the patient’s eyes between bedtime and fever was
treated by bleeding the patient [57]. During this period, the main medical decisionmaking process switched back to the theistic form that was in existence prior to the Greek
era but with the church as the main influence.
The late middle ages saw an increase in scientific knowledge with the founding of
medical schools between the 9th and 13th century across Europe. The human anatomy
became better understood with dissection of animals and post-mortem dissection of
humans. However, in the 14th century with the arrival of the dark plague across trade
routes killing one third of the population, people became frustrated with scientific
medicine when it offered no explanation or cure of the disease. The frustration with
scientific medicine led to the revival of magic-religious medical practice[57], [60].
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The renaissance period (14th-17th century) began just immediately following the
medieval period[63]. During this period, there was paradigm shift from superstitious and
magical medical practice to critical thinking, logic, observation and experiment [57],
[60], [63], [66], [67]. This led to an increase in scholarship and a renewed understanding
of Greek and Roman medicine [57], [60], [63], [66], [67]. Substantial advances were
made in anatomy, surgery, anesthesia and physicians began thinking critically about the
source of infectious diseases [57], [60], [63], [66], [67]. Mentally ill patients were no
longer kept in dungeons. The renaissance period was marked by freedom of expression
and liberalism and this greatly influenced the doctor-patient relationship [57], [60], [63],
[66], [67]. The relationship between the physician and patient at this time was structured
such that the patient had control of the encounter [60], [68]. Most of the people who saw
physicians were educated and upper class and the doctors had to compete to get patients
thus the power balance was tilted to the patient [60], [68]. This made the physicianpatient relationship more consumer centric.
Between the 18th and early 20th century, substantive innovations in the structure of
medical knowledge was achieved with the development of hospitals and the physician
played a more dominant role in the patient-doctor relationship [60], [68]. Most of the
people who utilized the hospital were poor and underprivileged and more passive [60],
[68].
With increasing development and discoveries in medical knowledge in the early
and mid 20th century, people of higher socio-economic status started utilizing physician
services more. The paternalistic form of the physician patient relationship was still
prevalent until the late 1970’s. However, in the latter part of the 20th century legal
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scholars and patients began to question the relationship between the patient and physician
and felt it was only ethical that patients be involved in their health care decisions
[50],[69], [70].
The advances in patients’ right’s movements and increasing medical malpractice
cases led to the establishment of the President's Commission for the Study of Ethical
Problems in Medicine and in Biomedical and Behavioral Research in 1978 to investigate
the problem of patient autonomy in their health care decision making process [16], [71].
The committee produced a report recommending that in every clinical encounter,
physicians should invite their patients to participate in dialogue about their clinical
decisions. The dialogue should be done using simple terminologies that the patient can
understand, explaining the different treatment options and their consequences to the
patient. This understanding and dialogue would enable the patient to contribute their
concerns and wishes in the decision-making process. The committee described the ideal
clinical decision making process as one where the decision about the patient’s treatment
is shared by the patient and the physician [71].
Clinical decision making has gone through several phases with varying
contributions from the patient and the physician. Currently, the relationship between the
doctor and patient is not as paternalistic as it used to be, however it has not fully evolved
to create that balance where clinical decision making is routinely shared by the patient
and provider. Several US health policy researchers believe that shared decision making is
one of the top ten elements to guide the redesign of health care in the United States
[10][72][73]. More specifically, they believe that shared decision making would lead to a
decrease in variation in practice, decreased healthcare costs, decreased use of invasive
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procedures, and increased quality of care [6], [7], [24], [72]–[76]. The next sections
describe the current state of SDM, its components and practice in more detail.
Clinical Decision Making
Most clinical encounters involve decisions such as to run a laboratory test,
administer/prescribe a medication, perform a procedure, refer a patient or recommend
behavioral modification [77]. Some of these decisions may appear simple and routine that
the physician may not consider it necessary to consider the patient’s treatment choice
[77]. However, each decision made about a patient should involve the patient because
just the way the physician is an expert in his field, so also is the patient is an expert on his
experience with that illness, social and emotional circumstance, attitude to risk, values
and treatment preference [10].
There are three main types of clinical decision making: paternalistic, shared and
informed decision making [17], [50], [78]. Each form of clinical decision making has its
unique characteristics even though there’s usually an overlap between the different forms
during clinical application [17], [50], [78]. There are other forms of decision making
which incorporates different components of the three main decision making models [15].
The shared decision making model has been described as the ideal patient-doctor
decision making relationship because the decision made considers the patient’s treatment
preference which may be based on lifestyle, expectations and the prevailing socioeconomic condition of the patient as well as the physician’s expertise and experience
[17], [50], [78]. That process where there is a merger of the patient’s expertise and the
physician’s expertise in the clinical encounter can be described as the shared decision
making process [10]. Central to the concept of shared decision making is medical ethics
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and law where the patient has a right to participate in their treatment decision making
process as much as they want [12], [79]. Additionally, increase in the range of treatment
options and interventions has made it more important to involve patients in their
treatment decisions [80].
Defining shared decision making

The earliest definitions of SDM were obscure, with lots of grey areas and overlap
between multiple treatment decision making models, giving each person room to come
up with their own interpretation and measurement of the concept [50], [77]. The earliest
description of shared decision making was by the President's Commission for the Study
of Ethical Problems in Medicine and in Biomedical and Behavioral Research. Even
though the commission described the process, their report did not include clear measures
for identifying SDM.
In the article Shared Decision-Making in the Medical Encounter: What Does it
Mean? (Or it Takes at Least Two to Tango) by Cathy Charles, Gafni, and Tim Whelan
Amiram, SDM was described as the ideal clinical decision making process and should
include a minimum of two participants (patient and physician) who share information and
deliberate about the preferred treatment which is then implemented [50]. The application
of this method of clinical decision making was described in the context of preference
sensitive conditions which have multiple viable treatment options [50].
In another article, Charles et al went on to further describe the SDM model as a
two way information exchange process where the physician provides the relevant medical
information to the patient, and the patient informs the physician about their values,
beliefs, and treatment preferences to enable both parties participate in the decision
process [17]. The emphasis on this article was the communication skills required to
17

practice SDM and the authors suggested approaches to SDM that can incorporate other
forms of clinical decision making. For example, the SDM model can be tweaked to
include some components of paternalism or informed decision making model for patients
who prefer other forms of decision making [17].
Godolphin described SDM as a tool to enable patients to become more
independent than they were prior to their encounter with their physicians. This
empowerment should be from the physician, whose primary role should be to treat and
promote patient autonomy [81].
The National Institute of Health defined SDM as ‘a collaborative process in which
patients and members of their clinical team work together to make health care decisions
informed by scientific evidence as well as patients’ own values and preferences’ [82].
Entwistle et al described two types of thinking about of SDM: the narrow and
broader understanding [83]. The narrow understanding of SDM involved presenting
information and treatment options to patients in such a way that the patient can
autonomously makes their healthcare decision [83]. They believed that the narrow
understanding of SDM assumed that physicians do not always work in the best interest of
the patient [83]. This narrow form of SDM takes away from the enabling relationship that
can develop between patients and their physicians with the physician acting as an
experienced guide in the decision making process [83]. The broader understanding of
SDM portrays a relationship between the physician and patient which is akin to
friendship [83]. The ‘friendship’ may influence the decisions being made but the
decisions are not imposed on the patient [83]. The treatment decisions in this form of
relationship may be influenced by the physician who like any good friend may challenge
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the way the patient considers the treatment options based on a deeper understanding of
the patient’s preferences [83]. Just as all friendships are unique to the individuals
involved in the relationship, the broader application of SDM has no clear demarcations of
how it should be applied. The physician and each patient would be the determinants of
the flow of the decision making process [83].
Brock and Wartman described the shared decision making as a complex process
involving division of labor between the patient and the physician. The complexity arises
when a competent patient is bent on making treatment decisions that the physician
believes is irrational and the ethical persuasive methods of convincing the patient against
their decision fails [84].
Coulter and Collins provided a more elaborate description of the process,
describing some of the decisions that can be done jointly between the physician and the
patient such as choosing a diagnostic test, treatments, management or support packages,
based on clinical evidence and the patient’s informed preferences. They described SDM
as a process of utilizing evidence-based information about options, outcomes and
uncertainties, together with decision support counselling to implement patients’ treatment
preferences’[10].
Makoul et al described what they believed were the components of SDM after
systematically reviewing 161 articles with conceptual definitions of SDM [77]. They
described two major categories: the essential and ideal components of SDM. The
essential components of SDM had to be present at the minimum for patients and
providers to engage in the process while the ideal components enhanced the decisionmaking experience, but are not considered necessary for SDM to take place [77]. The
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essential SDM components include a clear definition of the problem to be addressed,
presentation of treatment options, discussion of pros and cons of each option, a review of
the patient’s values and preferences, consideration of the patient’s self-efficacy,
utilization of the doctor’s knowledge, ensuring clarification or understanding of the
conversation, making a decision and scheduling follow up [77]. Makoul et al described
the ideal SDM encounter as an encounter that includes the following elements: unbiased
information sharing, definition of roles, presentation of evidence and mutual agreement
of the treatment option [77]. The literature showed that considering patient’s preferences
and mutual agreement on a treatment option were the most consistent essential and ideal
elements respectively [77].
Over the years several authors have contributed to the development of the
constructs of SDM. While none of the definitions are contrasting, most of the pioneer
authors have shown SDM from different unique perspectives. Their contributions
transformed the SDM process from a loose concept without clear constructs described by
the Presidents commission in the early 80’s to a process which can be measured. These
authors described the ideal setting and skills needed to instantiate routine practice of
SDM in the clinical encounter as well.
In summary, shared decision making is a clinical communication approach where
the patient is empowered to participate in their clinical decision making as much as they
want. The decision-making process should involve at least a minimum of two people
(physician and patient) who deliberate and come up with a mutually acceptable treatment
decision. The components of this treatment decision include information sharing,
deliberation and decision making. SDM requires proper communication skills by the
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physician to enable the patient to confidently participate in the clinical decision-making
process. The enabled patient and physician make decisions backed by scientific evidence
and the patient’s values.
Paternalistic and informed clinical decision-making approaches
The other two key forms of decision making are Paternalistic and the informed
decision making model [78].
Paternalistic Clinical decision-making approach
The paternalistic form of decision making can be described as the ‘professionalas-an agent model’ and was most predominant prior to the 1980s [62]. This decisionmaking model involved mainly a one-way directional flow of information from the
physician to the patient and the information passed on to the patient was just enough to
make or give an informed consent. There was no option of deliberation or consideration
of the other covert socio-economic circumstances in the patient’s life that may influence
their treatment choice [17]. The patient is passive and depends on the physician to make a
treatment decision that hopefully was in his best interest [17]. The physician took on a
dominating role under the assumption that he was the most knowledgeable between him
and the patient and his decisions were in the best interest of the patient [17]. The provider
assumes that he knows what is best for the patient and acts in the best interest of the
patient. However, the physician’s assumption may be incorrect [50]. Additionally, the
physicians were assumed to be smarter and were usually of a higher social class which
influenced patients to naturally defer to their authority [14], [17]. The prevailing
decision-making culture made it unquestioned and accepted as the norm by both the
patient and physician. With increased technology, availability of multiple treatment and
diagnostic options and with the rise of consumerism, paternalism began to be questioned
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[17]. The first official call to the end of paternalism was by the President’s commission of
ethics in 1982.
Even though no longer advocated, the paternalistic decision making process still
has utility in conditions with only one treatment option and in emergency situations [17],
[50]. The paternalistic form of decision making has been argued to be relevant during
emergency situations where the physician has to carry out a life sustaining intervention
[85].
However, even though emergency cases are seen mainly in the emergency
department, not all ED cases require a paternalistic approach. A systematic review
showed that SDM interventions had utility in the ED [85]. SDM interventions in the ED
led to increased patient knowledge and satisfaction with care, engagement in decision
making, as well as a reduced need for more health care utilization [85].
Informed decision making or Informed choice
In the informed decision making model, the physician is the technical expert who
relays information on the patient’s disease, treatment options and prognosis but he does
not participate in the treatment decision making process [79], [86]. The main difference
between this clinical decision-making model and SDM is that it lacks the deliberative and
decision-making components of SDM. The model empowers the patient to be the sole
decision maker, he ponders independently about his socio-economic and other prevailing
circumstances in his life as well as about the medical information provided by the
physician which he uses to make a treatment decision [79], [86]. With informed choice, a
patient is expected to make a treatment decision based on relevant, good quality
information, and the treatment decision reflects the patient’s values [87].
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The informed decision-making model is the most patient empowering of all the
different clinical decision-making models. However, the drawback to this decision
making model is that the expertise and experience of the physician is not put to best use
and it is assumed that the patient can comprehend all the information presented to him to
make a decision [15]. The SDM approach is different from the informed decision making
model because the informed decision making involves the patient making a unilateral
decision while in SDM the decision is collaborative [88].
Informed consent versus informed choice
Informed consent refers to a patient’s agreement to the physician’s recommended
treatment. It is the process where a patient authorizes the health care provider to provide a
healthcare service [12][89]. It does not consider or capture the degree to which the patient
comprehends the treatment, or if other options were presented to the patient. It simply is a
documentation that the treatment was not ‘imposed’ on the patient [50],[88]. Ideally,
informed consent should be the outcome of a paternalistic, shared or informed decision
making process [12]. With high risk interventions, an informed consent is usually
obtained but for low risk interventions, a simple consent is assumed when the patient
actually institutes the treatment recommended by the healthcare professional [12]. An
example of low risk situation is taking a medication for headache or applying a topical
cream to a rash [12].
However, in some settings, consent is given with forms filled and signatures
captured without the patient fully comprehending the treatment options, prognosis and
other intricate details of their illness and treatment [12]. In this setting, even though an
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informed consent form is filled and signed, it is actually not an informed consent, the
physician is simply covering his back for legal reasons [12].
On the other hand, informed choice or informed decision making refers to a
unilateral treatment decision a patient makes after reviewing all the treatment alternatives
[12][50].
Patient’s Preference in clinical decision making
Although SDM has been described as the ideal clinical decision making model,
not all patients are interested in being actively involved in their clinical decision making
process [90]. Additionally, some patients who indicate interest in participating in their
clinical decision making process do not always do so when given the opportunity [90].
This demonstrates that interest in the process does not always equate participation in
SDM [90]. Most studies have shown that majority of patients want to be informed of their
treatment options and a few prefer their providers to make the final decision [90]–[93].
There is a correlation in the discordance between desire and actual participation with
patient’s health status, gender, level of education, immigrant status, ethnicity, personality,
and the lack of an enabling environment for patients to articulate their preferences [90].
Most healthy people assume they would prefer to make their health decision
themselves but when patients develop chronic, life threatening illness they prefer their
providers to make the decision [90]. In mental health, a higher percentage of men
preferred a passive role as opposed to previous studies which showed that females
preferred passive roles [94]. A study done by Cuevas et al showed that about 64% of 507
psychiatric outpatients in the study preferred the SDM treatment model. But the reality
for about 86% of the patients in the study was a passive role in the clinical decision
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making process with their physician [94]. Similar to other studies, the findings in this
study showed that patients would prefer to deliberate on the different treatment options
with their healthcare provider but would prefer that the final decision be made by the
health care provider [94]. Another study showed that only 62% of patients prefer SDM
irrespective of gender, health status, and insurance status [19]. A study by McKinstry
showed that most patients appreciate a physician who listens to their concerns during the
history taking part of the encounter but had varying preference for participation in the
decision-making process. Their preference for clinical decision making was influenced
by age, presenting problem, social class and level of education [30]. Chiu et al found out
that in older patients, preference style for involvement in their healthcare decisions did
not influence satisfaction with their healthcare providers or making advance care
planning for medical care [95]. Kehl et al found out that irrespective of the patient’s
preference for decision making, provider controlled encounters yielded poorer patient
reported quality of care when compared to patient-centered care in lung and colorectal
cancer patients [91]. However, Blanchard et al found out that more older and sicker males
suffering from cancer who did not want to participate in their treatment decision were
slightly more satisfied than those who participated [92].
Less educated, low income, older, African American, and immigrant patients
preferred a passive role in the clinical decision making process [19],[96], [94]. Having a
regular physician was also associated with preferring SDM [19]. Family medicine
physicians who had received previous interviewing skills training involved their patients
more in the decision making process compared to other physician specialties [97].
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Although specific patient demographics prefer a particular role in their healthcare
decision making process, however the responsibility falls on the physician to assess the
patient’s decision-making style preference and the reason for the patient’s preference.
Physician background, training, practice volume, and professional autonomy are
determinants that affect the decision to routinely create an enabling environment for
involving patients in a shared decision making style [97]. Depending on the reason why a
patient who prefers a passive role, some passive patients may be stimulated to be more
involved when encouraged by their physician to participate in the treatment decision
making process.
Shared Decision Making in practice
Components of SDM
There are three main components of SDM. These components are information
exchange, deliberation and treatment decision.
1.

Information sharing: The first component of the SDM process involves

information exchange between the patient and physician. During this stage of the
encounter, the physician communicates the natural history of the disease, treatment
options including their risks and benefits, description of treatment procedure and resource
for more information of the disease [17]. The physician should gauge the amount of
information he passes across to the patient because some patients require more
information than others [17]. The patient on the other hand shares information on her
treatment preference based on previous experience, lifestyle and prevailing socioeconomic situation. The physician provides information based on his skills and
experience while the patient provides ‘self-knowledge’. The physician in most encounters
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sets the stage for information exchange by establishing an environment that is assuring
and encouraging for the patients to express their values. This involves explaining options
in a way the patient understands, giving the patient the opportunity to ask questions [5],
[50], [84].
2.

Deliberation: During this stage of the SDM process, the physician and patient

engage in a dialogue to jointly process the information shared in the information sharing
phase of the SDM process. The deliberation process requires time, flexibility, and mutual
respect [5]. The extent to which both parties differ in their ideologies, the more time,
flexibility and respect the relationship would need. This phase of the decision making
process requires good communication skills to come to a mutual agreement on the
treatment option [5], [17]. The provider needs to be sensitive to the patient because the
patient may feel intimidated by the physician’s knowledge, expertise and experience and
defer to the physician [17]. This becomes challenging for a physician who truly wants to
involve the patient in the decision-making process. On the other hand, some patients may
be well informed and independent in their decision-making process.
In the deliberation phase, patients should be given emotional support and guided
through any uncertainties they have about their health so they do not feel abandoned by
the physician [5], [17], [50]. During this phase, it is important that the patient understands
the things he needs to do to take care of his health depending on the option chosen [5],
[17], [50].
3.

Treatment Decision: The final component of SDM is the culmination of

information sharing and deliberation to finally decide on a treatment option. The
treatment chosen through this process usually incorporates the physician’s expertise and
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experience as well as the patient’s value. Thus, the treatment decision the patient and
physician agree on is based on adequate knowledge of the treatment options including
their pros and cons, and the choice is consistent with the personal values of the patient
[98], [99]. A major concern with this component of the SDM process is defining the
extent of patient involvement in the treatment decision for the decision to be shared [30].
Additionally, patients have varying interpretation of shared decision making, what some
patients may consider ‘shared’ others may call it ‘over-bearing’ [30]. However, SDM can
be said to have occurred if patients are involved in the decision-making process as much
as they desired [3].
The three components above highlight the different aspects of SDM, however
these events do not always occur linearly but in a continuum [50]. For example, a
decision could be made but the patient or physician could share more information that
can lead to more deliberation and another treatment choice.
In some clinical settings, the encounter between the patient and the physician may
be more complex involving multiple care providers, such as in teaching hospitals or in
patients who require care across multiple specialties [17], [100]. In such settings, some
institutions have involved decision coaches during the decision making process to ensure
an adequate and comfortable relationship where all parties can freely discuss their
treatment preference [100]. A decision coach is someone who has been trained to support
the patient's involvement in healthcare decision-making [100].
Facilitators and competencies for practicing SDM
Some of the factors that enhance the practice of SDM routinely include provider
motivation, the perception that SDM will lead to positive impact on the clinical process
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and patient outcomes [101].The competencies required for the routine practice of SDM in
clinical encounters go beyond the normal medical school communication curriculum
required for eliciting patient histories, passing negative information to the patient or
health promotion [101]. Towle et al described some core physician competencies that
facilitate SDM. They include the ability to develop a working partnership with the
patient, dialogue with the patient to determine the patient’s preferred decision making
role and amount of information the patient can handle, ability to validate patient’s ideas,
concerns and expectations, ability to identify choices, and deliberate with the patient on
the impact of their treatment decisions and the forgone alternatives, resolve conflict and
agree on an action plan which may include follow up visits [101]. Core competency
training in SDM among physicians has been shown to lead to better patient involvement
in the treatment decision making when compared to using risk communication aids which
target only one aspect of the SDM process [102].

Additional competence/requirement for facilitating SDM include being sensitive
to the patient by adjusting the tone of communication to the patient’s personality,
integrating the information with hope, negotiating and giving the patient control in the
decisional process from appointments to treatment options [103]. The patient portal of an
EHR provides a form of control to the patient by giving them the opportunity to make
their appointment themselves online, view their medical information and securely
communicate with their health care providers.
Just like physicians, there are competencies that enable patients to participate in
SDM. These competencies were developed by patients and patient educators and they
include the ability to 1) define their preferred role in the encounter; 2)find a physician to
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partner with; 3) articulate health problems, feelings, beliefs and expectations in an
objective and systematic way; 4) communicate with the physician to understand and
share relevant information; 5) access information; 6)evaluate information and 7)negotiate
decisions, give feedback, resolve conflict and agree on an action plan [101].

In addition to the competencies required by the patient and physician, there are
other factors that can facilitate SDM. Designing automatic triggers in the EHR systems
and engaging non-physicians in the distribution of SDM materials like decision aids
would facilitate SDM [53]. Furthermore, allowing extra time for decisions to be made,
involving family members and other members of the treatment team in discussions and
even distribution of power between patients and healthcare providers could facilitate
SDM [104]. The clinic infrastructure and patient care environments are other facilitators
of SDM implementation [105]. Adequate physical space, facilities to administer
audio/video decision aids, and adequate number of well-organized physician and staff
who are motivated to provide the support needed to integrate SDM into regular workflow
could make the practice of SDM more routine[105]. Developing adequate information
systems which could help identify and flag patients who are candidates for SDM or
integrating interventions that facilitate SDM such as decision aids in the workflow would
further facilitate the routine implementation of SDM [53].
Furthermore, the culture defined by Charles et al as, ‘as the expected (socially
sanctioned or legitimized) set of roles, attitudes, behavior and beliefs of health care
providers (in this case physicians) and patients about health and health care in general
and treatment decision-making in particular’ greatly influences the practice of SDM [78].
A collectively held understanding of the physician and patient’s expected role is a
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determinant of the direction a clinical encounter goes: whether it is paternalistic, SDM or
IDM decision making style [78].
Factors hindering SDM
The patient and healthcare professional characteristics, health system
infrastructure, and the type of decision that has to be made are factors that greatly
influence the implementation of SDM [104]. Some of the factors hindering the routine
practice of SDM are lack of time during the consultation, poor physicians’ predisposition
and communication skill, and patients’ who are ignorant about the role they could play in
making decisions about their treatment [101].

Providers have complained that several factors prevent them from routinely
involving patients in a shared treatment decision making process. Their workload and the
number of patients they need to see makes them so overworked that it is almost
impossible to involve patients in a dialogue about their preferences [53]. The time
scheduled to see each patient during an encounter is insufficient and constrains providers
from going through the SDM process [32], [106]. Additionally, studies have shown that
providers generally receive insufficient training in expressing uncertainty about treatment
options which is critical in engaging patients about their treatment [3], [53]. Providers
have also complained that sometimes SDM cannot be applied to all clinical situations and
patients [32], [106]. Some SDM proponents have criticized providers and claim that they
are unwilling to share power with their patients [3].

The barriers preventing patients from participating in SDM can be from the health
system organizational structure and events during the clinical encounter, some of which
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are similar to the barriers identified by providers [31]. Barriers from health system
organizational structure include time allocated to for each patient visit, lack of continuity
of care with the same provider, clinical workflow for ease of communication between
healthcare providers, and poor environmental conditions such as lack of privacy [31].

Barriers arising during the decision making interaction include patient
characteristics such as old age, African American, health condition (drug addiction for
example), decisional characteristics (like decisions about sexual-related side effects),
sensitive topics (like end of life discussions), interactional context factors (such as
presumptions about patient role), patients undervaluing their expertise relative to
clinicians, authoritative or dismissive clinicians, trust issues, expectations of involvement
in the decision making process, terminology used by clinicians [31].
Historically, there is a socially accepted role for patients and providers [14].
Providers are usually in a position of authority because of their expertise and it is
assumed that the ‘physician knows best’ and his actions are in the best interest of the
patient[14]. As such, most patients do not expect to be involved in the treatment decision
making and usually take on the passive role of relying on the physician for his opinion of
the best treatment option. In a qualitative study of perceived barriers to participating in
SDM, some patients responded that they assumed the passive role from fear of retribution
from questioning the recommendation of a physician [14].
The qualitative study showed that many of the patients felt that their physicians’
demeanor often prevented patients from contributing to the clinical decision making
process [14]. Some felt powerless and believed that their providers appeared very
knowledgeable and smart that they felt intimidated. Some did not feel respected or heard
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during the encounter and rather remained passive so they are not labelled as difficult
[14]. For SDM to be fully implemented, patients would have to be educated to demand
for involvement in their clinical decision making process [107].
Clinical Scenarios for SDM utilization
SDM can be utilized to enhance the patient experience in multiple clinical
scenarios such as the decision to undergo a screening or diagnostic test, medical or
surgical procedure, medication administration, life-style change and participation in selfmanagement education program or psychological intervention, as well as in the intensive
care unit (ICU) with patients and their proxy [10], [11],[108],[109]. The informed
Medical Decisions Foundation has since 2009 carried out demonstrations to show that
SDM can be conducted across primary care settings of varying sizes and in several
hospitals across the United States [53]. Additionally, SDM can be utilized during regular
clinic visits when medications are prescribed even though patients do not report a high
level of participation in decisions about common tests, medications and procedures [51],
[110]. SDM receives its highest advocacy in situations where there are multiple viable
treatment options and there is nonprofessional consensus on the best treatment [4], [50].
SDM has been utilized successfully for several health conditions such as localized
prostate cancer, atrial fibrillation, ischemic heart disease, fibromyalgia syndrome, dialysis
for renal disease and in various clinical settings like the intensive care unit, dental care,
primary care for Type 2 Diabetes Mellitus, psychiatry and mental health, and Preventive
health screening for colorectal cancer.
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a. Localized Prostate Cancer and Benign Prostate Hyperplasia (BPH):
The screening of prostate cancer has received one of the highest advocacy for
shared decision making because of the consequence of over treatment that occurs with
screening and the complications that arise with the treatment of disease that may not have
ever progressed beyond its stage at diagnosis [111]. The US Preventive Services Task
Force has recommended that the decision to undergo screening for prostate cancer should
be individualized and informed by the patient’s choice[112].
Prostate cancer has been described as a preference sensitive condition because
there are multiple viable treatment options which range from medication, to surgery or
watchful waiting in early stages of the disease [113]. Similar to localized prostate cancer,
surgery, medication and watchful waiting are viable treatment options of early stage BPH
[114]–[116].
b. Atrial fibrillation:
Atrial fibrillation has multiple viable antithrombotic treatment options. A
randomized control study which assessed the impact of a computerized decision aid
compared to usual paper-based guidelines administered to patients with atrial fibrillation
(antithrombotic medication) showed significantly lower decision conflict in the decision
aid group. Additionally, the decision aid group was less likely to start warfarin compared
to the paper-based guidelines group [117].
c. Ischemic Heart Disease:
There are three main treatment options for Ischemic Heart Disease (IHD):
Coronary artery bypass surgery, angioplasty and medical therapy [89]. In severe disease,
such as left main vessel or triple vessel disease with poor ventricular function, coronary
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artery bypass surgery is more effective in relieving angina [89]. However, for less severe
cases (stable angina) the best choice of treatment is not clear and involves a more complex
decision making process with varying treatment outcomes and tradeoffs between
functional status and symptom relief [89]. The Ischemic Heart Disease Shared Decision
Making Program (IHD SDP) is a decision aid which presents information on risks and
benefits of the three treatment options for stable angina to enable patients become active
partners in their treatment decisions [89]. Although the IHD SDP did not show any
increase in patients’ satisfaction with the decision making, but they had more knowledge
about their condition and treatment options and showed trends towards a more active role
in their clinical decision making [89].
d. Fibromyalgia Syndrome (FMS:)
The management of fibromyalgia syndrome is often frustrating for both the patient
and physician because of the pervasive nature of the pain and functional symptoms
associated with the syndrome [118]. There is currently no cure for the disease and
management consists mainly of alleviating the symptoms of the disease. The physicianpatient relationship in FMS is usually strained because of the uncertainty associated with
treatment modalities. The physicians feel the patients are illness focused while the patients
feel a lack of comprehension and skepticism from the providers. A study carried out in
Germany to implement SDM in FMS patient with a main outcome of quality of physician
patient interaction from the patient’s perspective. The SDM intervention was two
pronged: it provided a computer-based visualized information package to FMS patients
and SDM communication training for providers. The SDM intervention group reported a
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statistically significant better interaction with their doctors compared to the control group
[118].
e. Dialysis for Renal disease
The Renal Physicians Association (RPA) and the American Society of
Nephrology (ASN) in conjunction with representatives from multiple disciplines and
organizations recommend SDM for patients with acute renal failure or end stage renal
disease to aid in dialysis decision making [119]. This becomes much more important
when the burden of treatment becomes overwhelming for the patient.
f. Intensive Care Unit (ICU)
Most patients seen in the ICU are critically and about twenty percent of patient
who pass through the ICU end up dying [120]. The doctor-patient relationship in the ICU
is unique because at the time of presentation at the ICU, the patient is either comatose or
in a very critical state where anxiety levels are high for the patient, their family and the
physician who has to provide the critical care to keep the patient alive [108]. Despite the
heightened tension in the ICU, the American College of Critical Care Medicine (ACCM)
and American Thoracic Society (ATS) Ethics Committees recommend a collaborative
decision making process between the physician and patients or the patient proxy [121].
Additionally, shared decision making communication style has been shown to increase
satisfaction with care received in terminally ill patients in the ICU [120].
Adequate communication between the physician and the patient and their family
is essential and the SDM approach offers the best method for communication in this
setting and family centered communication is now considered a quality measure in the
ICU [108].
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An SDM intervention study was conducted at an internal medicine residency
program in New York City in 2011. The intervention involved a PowerPoint online SDM
training module followed by a four-hour communication skill building workshop at the
retreat [108].
The intervention was a training in communication skills required for shared
decision making in the critical care setting for internal medicine residents [108]. The
shared decision making training involved how to conduct family meetings to determine
goals of care and treatment plan based on mutual exchange of information between the
ICU team, patient, and family [108]. This intervention led to a self-reported increase in
skills associated with giving bad news, discussing goals of care and preferences for lifesustaining treatment, and determining code status preferences among the residents [108].
g. Dental care
There’s little literature of the utilization of SDM in dental care [122]. However,
Johnson et al developed a decision board (called EndoDB) to assist dentists elicit
patient’s treatment preference at the chairside at the University of Illinois at Chicago
College of Dentistry for either root canal or dental extraction [122]. The EndoDB
contained information on prognosis, benefits, risks and financial costs for various
treatment options [122]. This randomized control of EndoDB and usual care study
showed statistically significant improvement in knowledge but modest difference in
satisfaction and anxiety which wasn’t statistically significant [122].
h. Primary care for Type 2 Diabetes Mellitus
In most primary care chronic conditions (asthma, diabetes, hypertension), active
patient involvement would be required because of the chronic and evolving nature of the
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disease which requires patient participation for effective management [79]. Some diabetic
patients in Michigan State University were recruited for an SDM intervention study
[123]. The intervention involved providing patients with decision support workbooks,
patient education sessions and provider education. The primary goal with this SDM
intervention was to motivate patients to work with their physicians to develop goals for
the management of their diabetes. Other measures in this study was improved diabetes
outcomes (HbA1c levels, weight and blood pressure), and increased patients’ knowledge
and empowerment.
Pretest evaluation showed that few patients reported having a previous satisfying
decision-making experience with their providers. At the end of the study, patients
receiving the SDM intervention had improved rates of patient- provider SDM goal
formulation discussions, knowledge about diabetes and diabetes management outcomes
[123].
i. Psychiatry and mental health
In psychiatry and mental health clinical settings, SDM can be used when deciding
on adding a medication, stopping a medication, changing the time of administration of a
previously prescribed medication, changing the dosage of a medication, deciding not to
change a medication when an alternative was offered, or deciding on a non-medication
alternative [73]. A study carried out on childhood adolescent and mental health patients
showed that SDM can be implemented in these group of mental health patients if the
providers trust the patient, put in the effort, and are flexible in the implementation process
[104].
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j. Preventive health screening for colorectal cancer
The US Preventive Services Task Force calls for the implementation of SDM in
colorectal cancer screening [109]. There are three different colorectal cancer screening
options for people 50 to 75 years: 1) colonoscopy every 10 years, 2) fecal occult blood
tests annually, 3) fecal occult blood tests every 3 years combined with flexible
sigmoidoscopy every 5 years [109]. Dolan et al found out that using a multi-criteria
decision analysis can aid the implementation SDM in colorectal cancer screening [109].
SDM in acute vs chronic care
The application of SDM in acute and chronic care varies. In acute care, for
example breast cancer, the decision to be made is usually irreversible and sometimes with
an outcome that is life-changing. However, in chronic care, there is the option of
revisiting the treatment decision and reevaluating the patient’s treatment goal and the
changing socio-economic circumstance which could influence treatment choice and
compliance [79],[97]. Additionally, the natural course of chronic diseases changes over
time such that the mix of the change in the condition and outside circumstances might
change goals.
In an acute care clinical decision making setting, for example deciding between
chemotherapy or surgery for recently diagnosed breast cancer or leg amputation versus
revascularization for a diabetic with ischemic vascular disease, the critical decision
usually is a time event and there is a narrow window of opportunity to consider treatment
choices, and the decision is usually irreversible [79]. The decision is usually made with
certain level of urgency because a lack of immediate decision may lead to fatality for
example metastasis or sepsis and even death [79]. Some patients recover from their acute
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conditions and like most people who live long, they may end up with some chronic
condition [79].
However, in a chronic care decision making settings, for example uncomplicated
type 2 diabetes or hypertension, multiple decisions would be taken over long periods of
time since these conditions in most cases have to be managed over a lifetime. There are
multiple windows of opportunity to consider treatment choices and the decisions are
reversible [79], [97].
SDM in Preference Sensitive conditions
There is ample evidence that show that SDM can be used in primary care,
however it has its highest utility and advocacy for preference sensitive conditions [10],
[11],[108],[109], [124]. Preference sensitive conditions are conditions where there are
multiple viable treatment options with tradeoffs between quality of life and length of life
[124]. Early stages of prostate and breast cancer are examples of preference sensitive
conditions that occur in males and females respectively. Others include chronic
cholecystitis, chronic stable angina, benign uterine condition, hip osteoarthritis,
Rheumatoid arthritis, herniated disc or spinal stenosis, claudication, and carotid stenosis
[23], [24].
For example, localized breast cancer is a preference sensitive condition and about
one in eight women will be diagnosed with breast cancer in their lifetime [125]. There are
2 main treatment options for localized breast cancer: 1) Breast conserving surgery
(lumpectomy) with radiation or 2) Mastectomy [124]. Both treatment options have
comparable survival rates but have difference cosmetic effect and recurrence rate.
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Most patients with preference sensitive conditions are usually at cross-roads on
the best treatment to choose when they are given all the options. However, in cases where
the provider decides on the best treatment option without deliberating with the patient, he
loses the opportunity to consider the patient’s treatment preference in the treatment
decision. Apart from making the patient feel empowered, an SDM process would reduce
the chances of the patient developing treatment regret [126]. Additionally, even though a
provider may have details of a patient’s family and socio-economic circumstance, it
should be considered that these situations are not constant as such patients should be fully
involved in their treatment decisions.
In cases where the provider recommends a particular treatment option, patients
feel less involved in their treatment decision [124]. It has been shown that early stage
breast cancer patients who were presented multiple treatment options were more likely to
feel more involved in their treatment process, had increased knowledge, risk
comprehension and less decision uncertainty [124], [127].
Effects of SDM
SDM has been advocated as the most ideal clinical decision making model
because it respects the patient’s autonomy, gives the patient a sense of ownership of their
health choices and it is beneficial for health and wellbeing [80]. The Affordable Care Act
enacted in 2011 has several provisions that promote SDM. Section 3506 of the Act
emphasizes the importance of a collaborative relationship between patients and clinicians
in decision-making process when there are trade-offs among treatment options, ensuring
the incorporation of patient preferences and values into the medical plan however, there
is no clarity on how the implementation should be measured or incentivized [128]–[130].
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Additionally, the United States Preventive Services Task Force (USPSTF) strongly
recommends SDM for several screening and preventive services like colonoscopy for
colorectal cancer, mammography for breast cancer and prostate specific antigen for
prostate cancer [131]–[133].
There are various potential benefits of shared decision making to the patient and
the health system. Many health service researchers believe that routine SDM in the
clinical encounter will lead to a reduction in practice variation and health care costs [24],
[136], [137]. Several factors influence variation in care, most of them related to the
physician, location and the physician’s practice style [24], [134], [135]. However only
patient specific factors should lead to variation in care [24], [134], [135].
SDM has been shown to lead to increased patient self-esteem, improved selfmanagement and health coping strategies, greater adherence to treatment, less decisional
regret, and improved satisfaction with the clinical process [136], [104],[137]. SDM
produces/enhances these outcomes by promoting self-efficacy thus the enabled patients
can become active participants in their clinical decision making process [104].
A systematic review of 11 randomized control trials conducted in 2008 showed
that SDM had varying effects on outcomes [9]. The outcomes measured were patient
satisfaction, psychological and physical well-being, medication adherence, and increased
knowledge. Five of the studies showed no statistically significant difference in outcomes
between SDM intervention groups and controls. One of seven studies which measured
patient satisfaction reported an increase in patient satisfaction; two of five studies showed
better psychological and physical well-being in the intervention group compared to
controls and one study showed better adherence to antidepressant medication compliance
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nine to twelve months after the intervention. Two of 3 studies which measured
knowledge showed patients in the intervention group were significantly more
knowledgeable about their health conditions when compared to controls even though
these studies involved only a single session of SDM intervention in patients SDM [9].
A multi-media SDM educational program for men diagnosed with benign
prostatic hyperplasia did not show any difference in patient’s treatment choices or
satisfaction with their treatment decision between groups [138]. However, the SDM
group were more knowledgeable, had a higher satisfaction with the decision making
process, perception of health status and physical functioning [138].
SDM promotes patients’ autonomy but the practice becomes controversial when a
competent patient makes choices that are not in their best interest. This creates a dilemma
for the physician to either respect’s the patients autonomy or revert to the paternalistic
approach where the physician makes the decision for the patient [84].The varying effects
of SDM may be from the way it was measured.
Measuring Shared Decision
The multiple definitions and varying components of SDM make it challenging to
develop uniform measurement of the concept. In January 2017, the National Institute of
Health (NIH) created an R01 funding opportunity for Health Service researchers to
develop, test and evaluate measures of SDM in clinical settings
(https://grants.nih.gov/grants/guide/pa-files/PA-16-424.html) [82].
In health service research, there are debates between process and outcome
measurements as the best indicators for health system performance [139], [140], [141].
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However, the context in which the system analysis is done determines whether to use
process or outcomes measure [139].
Shared decision making has been defined by some authors as a process, and
others have described the concept as an outcome [98], [118], [142], [143]. SDM can be
measured using indicators that capture either the process or the overall outcome of the
process [144].
Process and outcome measures
Process indicators measure the specific steps in a process that lead to a target
outcome metric [139]. When assessed correctly, process indicators show the specific
loopholes in a delivery system and are essential for outcome improvement. Process
measures improve quality by enabling organizations to identify the source of variation in
care delivery. Overall, process measure indicators are more sensitive than outcome
measure indicators in identifying the quality and characteristic of the service provided
[139]. Additionally, process measures are easier to interpret because the actions which
lead to the outcome are easier to identify and as such remedial actions which can
influence outcome can be implemented [139].
On the other hand, outcome measures are indicators of the overall goal and
achievement of a health system [140]. They represent the end-point, which a system or
intervention sets to achieve and are the main indicators that are targets for health system
improvements and often used for comparison between systems at international, national
and local levels. Health service researchers measure outcomes as a validation of the
process, that is, the end result should speak for itself [140].Outcome measures can be
subjective or objective indicators of quality of care. Self-reported quality of care is an
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example of a subjective outcome measure. Examples of objective outcome measures
include readmission rates, disease state, disability and mortality. On surface value,
outcome measure would seem like the benchmark for measuring the success or effect of
an intervention.
Measuring Shared Decision Making as an outcome

Outcome measures have found its relevance in health service research because
they directly measure the overall effect of the different aspects of the service delivery
process [139]. The main drawback in using outcome as a measurement of a process is
that it may lead to failure in determining and including other important measures that
contribute to the outcome, as such leading to wrong conclusions about the intervention
[139]. However, when broad perspectives are required, outcome measures are the best
indicators of health system performance [139]. Majority of research in SDM have
focused on outcome measures such as knowledge, risk perception, compliance with
treatment, satisfaction with the decision made, patient’s anxiety and confidence that the
most appropriate treatment has been chosen [144]. Other examples of outcomes of
interest are patient’s experience, use of services and costs, and health behavior and health
status[145].
Most of the time, the main outcome measure in SDM is not the decision itself
because there are so many factors involved in healthcare decision making [98]. To
measure effective decision making, several scales have been developed to measure the
outcome of the decision. Some of them include the satisfaction with decision scale,
decisional conflict scale etc. [143].
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Measuring Shared Decision Making as a process

Measuring the different process or steps in the whole SDM process can help an
evaluator identify the shortcomings in the decision-making process. The main challenge
in measuring the SDM process is determining whose perspective of SDM to measure and
what steps of the process to measure. Some researchers have developed tools to measure
the perspective of both the patient and the provider and some have included tools for
third parties observing the encounter [146], [147, p.] [148]. Most SDM researchers in the
past have focused on the outcomes of shared decision-making with little research on the
process [82]. There is a call for more research on valid and reliable indicator measures for
the SDM process [82].
Based on existing literature, it is difficult and sometimes almost impossible to
determine the best measure or indicator for system performance between process or
outcome measures. Paul Batalden, summarizes this controversy that “Every system is
perfectly designed to get the results it gets”, that is to say the process when adequately
measured should be the same as the outcome measure [149]. In this study, we will be
measuring both the process and outcome.
Instruments for measuring/evaluating SDM
Most instruments measuring the outcome of SDM interventions measure values
and preferences in decision making, patients' knowledge, participation in the decisionmaking process, decisional conflict, the treatment choice, satisfaction with decision, and
health status [150], [151].
Charles et al suggest that the true measurement of SDM is when both parties are
satisfied with their level of involvement in the decision making process [50].
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SDM can be measured at 3 levels: antecedents prior to the decision making
process, the actual process and the outcome [9], [152]. Examples of these levels are the
patient’s role preference, patient and/or provider behavior and decisional conflict
respectively [9], [152]. Additionally, SDM can be measured from the view point of the
patient, provider or an independent observer [153].
The 9-item Shared Decision Making Questionnaire (SDM-Q-9) is a commonly
used patient reported instrument that was modified from a previously validated SDM
measure called the Shared Decision Making Questionnaire (SDM-Q) [146], [147, p.].
SDM-Q was a 11 item questionnaire that was designed to measure the whole SDM
process [146]. However, the SDM-Q questionnaire did not sufficiently cover all the steps
in the SDM process [147]. SDM-Q was revised to be a 9 item instrument (SDM-Q-9) that
measures each step of the SDM process from the perspective of the patient [147].
Subsequently, a modified version of SDM-Q-9 that measures the processes of SDM from
the perspective of the physician, the SDM-Q-Doc, was developed with wordings similar
to the SMD-Q-9 instrument [153]. A systematic review by Doherr et al has shown that
both SDM-Q-9 and SDM-Q-Doc can be used simultaneously or independently to
implement and assess SDM [152].
MAPPIN'SDM is an instrument that concurrently measures SDM from three
perspectives: the patient, provider and observer [154]. It allows comparison between the
observer assessment and subjective response from the patient and physician using
‘behavior and results’ as its two key constructs to measure involvement in the decision
making process [154]. Behavior was measured by observation of SDM behavior and
results refers to the immediate perception of SDM after an encounter [154]. A validation
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of the scale showed no relationship between the observer’s report of SDM and the
subjective report by the patient and the physician. The subjective report by the physician
and patient was more correlated contrary to what was found in previous studies where
providers and patients were incongruent in their assessment of SDM in the clinical
encounter[154].
The OPTION instrument is another commonly used instrument for measuring
SDM which was created from the synthesis of information from a systematic review
[155]. It focuses on the behaviors initiated by the health care provider to engage patients.
The instrument has 12 items which measures the physician’s attitude towards patient
engagement [155]. A systematic review of 33 studies involving the OPTION scale
showed low patient engagement by physicians during routine clinical encounters when
there was no SDM intervention. The authors also found out that an engaging physician
patient relationship did not rely solely on the physicians initiating it, SDM interventions
targeting patients also increased the overall OPTIONS score for physicians [155].
Another study used the OPTION scale to examine physicians’ communication of
uncertainty and its impact on patients’ decisions and decision satisfaction in breast cancer
patients [148]. In this study, women whose providers conveyed uncertainty about
treatment options were more dissatisfied compared to those who providers did not. An
explanation for the dissatisfaction with discussing uncertainty in the clinical decision
making process may be the added anxiety uncertainly may cause in the disease process
[148].
Studies have shown a disconnect between patient reported assessment of SDM
and observed SDM because sometimes patients do not realize that a decision was made
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during an encounter [156]. Other instruments that measure third party observation of
SDM include: Calgary-Cambridge Observation Guides [157], [158]; Communication and
Decision-Making Checklist [158]; Elements of Informed Decision-Making [88], [158];
Euro-Communication Scale [159]; Levels of Physician Involvement [160]. Another
instrument that measures physician participation in SDM is the Rochester Participatory
Decision-Making Scale (RPAD) [161]. RPADS measures the extent of collaboration
between the doctor and patient during the clinical decision making process using a survey
administered to patients [161].
A modified version of the observer OPTION scale is the dyadic OPTION scale.
The Dyadic OPTION scale measures the perceived involvement and interdependence of
physicians and patients in clinical decision making administered after a clinical encounter
[162]–[164]. Unlike the observer OPTION scale, the dyadic OPTION scale takes into
account the internal perceptions and thought process of those involved in the decision
making beyond what is observed [165].
Another measure developed for the assessment of SDM is CollaboRATE, a
patient reported measure of SDM [156]. The CollaboRATE tool was developed because
the authors believed that most of the measures for SDM especially the patient reported
aspect were too lengthy, did not fit into the routine workflow of clinical practice, did not
include qualitative methods (focus groups, interviews or cognitive interviews) that ensure
the questions could accurately interpreted by patients [156], [164]. Additionally, some
SDM measurement tools included the terms ‘decisions’, or ‘options’ which may reduce
the interpretability and validity of the measure [156]. This scale comprises of 3 questions
which were developed over 4 iterative stages: 1) framing of the questions based on
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available literature, 2) two stages of cognitive interviewing and 3) pilot testing. The
questions in this scale measure the effort made at explaining the patient’s health issue
(How much effort was made to help you understand your health issues?), preference
elicitation (How much effort was made to listen to the things that matter most to you
about your health issues?) and integration of patient’s preference in the decision making
process (How much effort was made to include what matters most to you in choosing
what to do next?) [156]. Each question was on a scale of 1-10, 1 being the least score of
effort made and 10 the highest score with a total measure of 30. The authors believe that
the framing of these questions would make it a convenient and reliable tool to measure
SDM in all clinical settings because it is brief and the wording was validated by lay
people and patients [156]. The main strength of this methods is the utilization of iterative
cognitive interviewing methods while the main limitation was the homogeneity of the
study participants [156].
The Control Preference Scale (CPS) developed from a grounded theory measures
the degree of control chronically ill patients want to assume in their treatment decisions
[151], [166]. The measurement scale consists of 5 cards (lettered A to E) with drawings
and written statements to show their degree of interest in involvement in their treatment
decision. Card A represents the most active role with the patient assuming full control of
the decision-making process, card C represents a mid-range of the scale with both patient
and physician making the decision and card E is the most passive role with only the
physician making the decision. Cards B and D are in between A and C and C and E
respectively. The administration of the scale involves successive, random or fixed-order
presentation of the cards for comparison of all the possible combinations and
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interpretation involves permutation. Although CPS provides information about patient’s
preference along a range, however, it is complex, requires extensive training of the
administrator and subject fatigue may ensue during administration of the scale. Patient’s
choice should guide the decision and patients are more conservative when given the
option to make a choice [166].
The decisional conflict scale (DCS) which has the English, French, Spanish and
Dutch versions measures ‘health- care consumers’ decision uncertainty, the factors
contributing to the uncertainty, and health-care consumers’ perceived effective decision
making’ [21], [98]. This scale measures and assigns a value to the uncertainly involved in
decision making as well as factors contributing to uncertainty in the SDM process [98].
Decisional conflict can be described as ‘the simultaneous opposing tendencies within the
individual to accept or reject a given course’ or ‘an individual’s perception of uncertainty
about the course of action to take when the choices involve risk, loss, regret, or a
challenge to personal life values’ [21], [98], [167].
There are three subscales to measure decisional conflict using the DCS. The first
is the uncertainty subscale, the second is the effective decision making subscale and the
last is the factors contributing to uncertainty subscale [98]. The DCS was assessed for
reliability by checking for internal consistency between subscales in breast cancer
patients. The validity was assessed by checking for consistency between accepting the
invitation for influenza vaccination and actually getting the vaccine [98].
SURE is a screening test for decisional conflict in patients and has been validated
among French and English speaking patients [21]. The tool is designed to aid healthcare
providers in quickly identifying patients facing decisional conflict. Its scoring system is
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negatively correlated to the DCS and has only 4 questions requiring less time to
administer compared to the DCS [21]. The 4 items measured are: sure of myself,
understand information, risk benefit ration and encouragement with binary response of
yes or no [21]. The main advantage of this tool is its short format [21].
COMRADE, an acronym for combined outcome measure for risk communication
and treatment decision making effectiveness, is a patient based instrument for measuring
the extent and effectiveness of risk communication to enable SDM across multiple
clinical settings [99]. Risk communication in a clinical encounter is a two-way flow of
information about the risks of a treatment and risk attitudes between the provider and
patient [99]. COMRADE is a 20 item instrument with two main factors: satisfaction with
risk communication and confidence in decision which measure the SDM process and
affective outcome of SDM response respectively [99].
Another instrument which measures the SDM outcome is the 6-item satisfaction
with decision scale [143]. This scale was designed to specifically measure only the
patient’s overall satisfaction with their treatment decision and not the other aspects of
care they received or the health system [143],[168]. Other scales include the desire to
participate in the decision scale, satisfaction with decision scales, post decision
satisfaction, satisfaction with decision, satisfaction with information, satisfaction with
information, patient enablement instrument and Patient’s perceived involvement in care
scale [143].
The perceived involvement in care scale (PICS) is a patient reported questionnaire
that measures the SDM process. It measures how the doctor facilitates patient
involvement, the level of information exchange, and the extent of patient participation in
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decision making [169]. This scale has been modified to measure pain M-PICS and I-PICS
is the Iceland version of MP-PICS[170], [171].
A study by Kaiser Permanente used a simpler survey to measure SDM. SDM was
measured in this study as two survey question, modified from the interpersonal processes
of Care instrument: In the last 12 months, how often did your personal physician involve
you in making decisions about your care as much you wanted, and in the last 12 months,
how often did your personal physician seem to understand the kinds of problems you
have in carrying out recommended treatments [172]–[174].
Kaplan et al describe patient reported health status and patient satisfaction as
justifiable outcome measures for gauging the effectiveness and quality of the physician
patient relationship [20]. They described a relationship between a patient’s health
outcome and the physician patient interaction. Patients who are engaged usually report
better physician patient relationship compared to those who are not engaged [20].
Additionally, provisions in the Affordable Care Act measures physician performance by
assessing patients’ satisfaction with their health care provider using the Clinician and
Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS)
surveys [175]. Furthermore, patient reported health status have shown to be a valid and
reliable measure of health status over the years across different settings [176].
SDM interventions
Information sharing is a prerequisite to shared decision-making and most SDM
interventions target areas and methods to improve the quality and quantity of information
patients have, patient’s self-efficacy and patient-provider communication skill to enhance
bilateral information sharing [50].
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Three main forms of Shared Decision Making interventions exist:1) interventions
that target both patient and healthcare provider 2) interventions which target the provider
and 3) interventions which target the patient [177], [178].
Interventions targeting both the patient and healthcare provider
Interventions which target patient and the provider usually include educational
meetings, patient mediated interventions, distribution of education materials, audit and
feedback, barriers assessment and educational outreach visits [177], [178]. Two examples
of such interventions targeting patients and providers are described below.
Ruland et al developed a computerized support system using tablet computer to
assess the most relevant patient reported symptoms that patients with preference sensitive
conditions would prefer to be addressed by their physicians. The details from the
patients’ choices was then presented to the physician who used that information in
addressing the patient’s needs during the consultation. This study found a higher
congruence between patient reported symptoms and symptoms addressed by their
providers [179].
Schulman-Green et al suggested goal setting as a strategy to encourage older
patients to participate in their clinical decision making. The study focused on geriatric
population because generally, older people prefer a paternalistic clinical decision making
process [180]. In this study, the authors carried out a focus group study to evaluate how
goal setting can stimulate the rate at which older patients participate in their treatment
decision making [180]. Although goal setting is commonly used in most industries, the
idea of discussing and setting goals was a new idea for both providers and patients [180].
Most providers and patients did not fully understand the context in which goals could be
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discussed in the clinic [180]. Patients have multiple life goals and the clinical encounter
may become complex if the framework for goal setting is not clearly defined [180].
Interventions targeting the healthcare provider
The most common SDM interventions for healthcare providers target their
communication skills [181]. Interventions include educational meetings, audit and
feedback and distribution of educational materials [177], [178]. The regular medical
school curriculum is not designed to train physicians on shared decision making so most
physicians lack the communication skills required to stimulate and practice SDM [108].
Communication interventions designed specifically to train physicians on shared
decision making have been effective in improving the doctor patient relationship [118].
An example of such intervention was a study for providers attending to Fibromyalgia
Muscular Syndrome patients in Germany[118]. After the intervention, the patients
reported a significantly improved relationship between them and their providers [118].
The intervention involved 12 training sessions on SDM communication techniques for
providers with each session lasting an hour and a half [118].
Interventions targeting the patient
Most of the patient focused interventions aim to improve health literacy, clinical
decision making, self-efficacy and patient safety [145]. There are several forms of SDM
interventions targeting patients and the most popular is the patient decision aid. Lee et al,
proponents of Shared Decision Making, have suggested that SDM interventions like
decision aids be developed and utilized for the 20 most common procedures [7]. To
ensure implementation and utilization of the decision aids, they suggest that the Center
for Medicare and Medicaid (CMS) to collaborate with Patient-Centered Outcomes
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Research Institute (PCORI) to certify the decision aids and impose a 10- 20% reduction
in Medicare payment claims for providers who fail to routinely use or document the use
of shared decision making and decision aids [7]. This form of control of health service
quality is like the measures taken by CMS to reduce hospital readmission and increase
EHR adoption rates. Other interventions include videotape-assisted patient education
material, electronic health records, pamphlets, and teaching [177], [178].
a. Decision aids
Decision aids (DA) are mediums used to promote decision making capacity of
patients and come in a variety of forms, ranging from printed material (pamphlets to
booklets) to multimedia media to interactive websites which enable the viewer to learn
about the topic and treatment options as much as they are interested [10], [182]. Decision
aids are the most common SDM interventions and sometimes used interchangeably with
SDM, with more than 500 developed in the last two decades [183]. The ideal DA should
provide clear, comprehensible information about the condition and the treatment or
support options, outlining outcomes, risks and uncertainties in a clear, comprehensible
and unbiased manner [7], [183], [184],[185].
Although several DA have been developed for most conditions, the uptake is low
and they are still not widely used [183]. The skill, tools and trust are physician constraints
challenging the utilization of decision aids in the routine clinical encounter, while
patients need information and support [183]. Another drawback in the use of DA in the
clinical encounter is that some providers lack information on the risk estimate of some
treatments and tests and may be uncertain with the probability of developing some of the
side effects/outcomes [183].
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More recent decision aids have been designed to be used collaboratively by the
patient and provider during the clinical encounter to stimulate a more participatory
decision making approach, and sometimes administered through the patient portal [183].
The patient portal becomes a great tool to administer decision aids when the physician
and patient are constrained by time during the routine clinical encounter [183].
Administering the DA through the portal gives the patients more time at home to review
the decision aid and sometimes consult with friends and family members before returning
to discuss their treatment preference [183].
There is a patient decision aid library (https://decisionaid.ohri.ca) which contains
a repository of DAs and tutorials to help train providers on SDM [186]. The DA has
shown varying outcomes in different health settings. For example, it had no influence on
preference for circumcision in newborns, screening for breast cancer gene and prenatal
testing, dental surgery, hormone therapy [183],[185] [187]. However, DA reduced
preference for screening with prostate specific antigen and led to patients taking a more
active role in their clinical decision making process [185].
b. Videotape-assisted patient education material
Videotape-assisted patient education material can be used to increase patient selfefficacy for SDM. A study on prostate cancer screening for men ages 45-70 years using
video-assisted education material showed an increase in knowledge about prostate cancer
and subsequent decline in PSA screening among the intervention group when compared
to the control. The patients attributed the change in knowledge and desire for PSA
screening to the videotape [188], [189].
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c. Using Electronic Health Records
More recently, electronic health records have become widely used in the United
States. Concurrent to the increased utilization of electronic health records is the research
on patient centered and comparative effectiveness research [190]. The tethered patient
portal of an EHR can be used to collect patient preferences and outcomes directly from
the patient [190]. This can be done by administering questionnaires and surveys via the
patient portal[190].
Leslie et al described a four-phased Computer Decision Support (CDS) tool
integrated into the EHR clinical workflow for stimulating and implementing routine
SDM [182].
The Personal Health Record
There are several definitions of the personal health record. The Markle foundation
described the PHR as “a set of computer-based tools that allow people to access and
coordinate their lifelong health information and make appropriate parts of it available to
those who need it” [34], [191]. The American Health Information Management
Association (AHIMA) defines the personal health record as “an electronic, lifelong
resource of health information needed by individuals to make health decision” [192]. The
National Alliance for Health Information Technology (NAHIT), defined the PHR as “an
electronic record of health-related information on an individual that conforms to
nationally recognized interoperability standards and that can be drawn from multiple
sources while being managed, shared and controlled by the individual” [193].
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Prior to the Meaningful use act, most patients were given access to their personal
health records through their health insurers, employers, health plans or healthcare
providers [34]. There are three main types of personal health records: the integrated,
standalone and tethered personal health records [34], [194], [195].
The tethered PHR also known as the patient portal is a read-only extension of the
provider’s Electronic Health Record system and the patient is given web-based secure
access [34], [194]. The patient’s healthcare provider is responsible for maintaining the
patient portal [196]. The patient cannot edit information from the tethered PHR [194].
This is the PHR record that is most prevalent since the HITECH Act [34]. When the
patient portal is utilized, it is expected to improve quality, safety, efficiency, decreased
cost and increase patient satisfaction [34]. Examples of EHR vendors that provide the
patient portals are the Epic System (MyChart), the Department of Veterans Affairs
(MyHealtheVet).
The standalone PHR is a self-maintained PHR. The patient is responsible for
documenting the details of their health records into the system [194], [196].It is time
consuming for patients to manually enter their health information into the record system
and physicians are concerned about the integrity of the information in the PHR when
patients document the information themselves [194], [195], [197]. Blue Cross and Blue
Shield and American’s Health Insurance Plans offered PHRs to its members; as well as
Intel, Wal-Mart, Applied Materials, British Petroleum, Pitney Bowes developed a webbased standalone portal for patients [34]. WebMD, WellMed, Microsoft, Google and
CBSHealthWatch provide commercial PHR systems to patients who may not have access
through their providers or who desire a more comprehensive PHR system [197].
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The integrated personal health record is an interoperable documentation of the
patient’s health recorder that contains information from multiple sources which the
patient can share [196]–[198]. It is a combination of the tethered and self-maintained
PHR. Although the provider provides access to the patient and contributes to the
information, the patient can edit and import more information from multiple sources like
pharmacies, insurance claims, other healthcare providers and from home medical devices
[195], [196]. Google Health and Microsoft Health Vault designed this form of PHR
[196].
The PHR can be used to collect information, share information, exchange
information, and help patients manage their information. The patient portal offers several
potential benefits. It is time saving, as patients do not always have to present in the clinic
for medication refills or call the doctor’s office to book an appointment. The patient
portal also has the potential to increase compliance when clinical alerts are sent to
patients about their management plans. A study showed that the patient portal increased
compliance in portal users up to 12% - 26% with regards to monitoring, screening and
diagnostic tests [194].
The patient portal has the potential for improved relationships between the patient
and provider as it provides a platform for direct communication between the patient and
provider beyond the regular clinical interaction [194]. A survey showed that more than
50% of patients who used the PHR had more questions for their providers than they
would have had without using the portal [194]. Additionally, the patient may become
more empowered and feel a degree of control in their healthcare management as they
access and review their medical information at their convenience [194]. Despite these
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potential benefits, studies have shown mixed evidence of the effects of patient portals on
patient outcomes, satisfaction and efficiency [49], [199]–[201]. A study conducted in
2006 showed that patients were willing to pay to have access to their health records
electronically [201].
Not all patients and providers are enthusiastic about using the patient portal. Some
of the reasons for the lack of enthusiasm with using the portal include the following:
1.

Concerns about privacy and security of their health records: The privacy and

security of the electronic PHR is a major concern to patients from fear of unauthorized
access to their health records [194], [197].
2.

The digital divide in patients who do not have access to the internet and/or who

are not technologically savvy may lead to lack of adoption of the PHR and its benefits
[194], [197]. These population of patients usually fall into the lower socio-economic
status and are the group of patients with more debilitating chronic illness who would
benefit the most from accessing their healthcare information through the patient portal
[194].
3.

Another drawback with the patient portal is the lack of interoperability. A patient

who has multiple healthcare providers in different networks may end up having multiple
patient portals [194], [200].
4.

Additionally, the technicality of medical terminology in the patient portal is a

concern to patients. A study showed that 80% of patients have to use the internet to
interpret some terminology in their personal health record [197].
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The main draw back with physicians about the PHR is that the time spent sending
and reviewing information from the patient via the portal is not directly reimbursed so
providers may not be that motivated to engage their patients through the portal [34], [35].
It is generally assumed that the patient portal of an EHR promotes SDM [182].
Currently, the HITECH incentive program mandates physicians to provide patients with a
portal for them to remotely access their health information however, beyond the
provision of the portal, the law does not include the details on how to use the portal to
engage patients, or elicit their preferences [182].
Components of the patient portal
At the minimum, from the portal, a patient can access information on their
medication list, problem list, test results, list of allergies, after visit summary and
education or disease management information. Beyond accessing medical information,
patients can communicate securely with their providers, schedule appointments, request
for medication refills and pay their medical bills through this portal [194], [198].
Utilization of patient portal and shared decision making
There has been a gradual increase in the adoption and utilization of PHRs in the
US [202] [203]. In 2007, the Personalized Health Information Act bill was introduced to
congress. It was an financial incentive program for physicians to provide patients with
access to their health records [204]. The bill did not pass at congress. However, in 2009
the meaningful use (MU) component of the HITECH Act has increased portal access and
utilization across the US. The MU act required physicians to provide portal access and
functionalities for at least 5% of their patients by 2014 to get reimbursed [202]. The
adoption and utilization rate measured in a nationally representative sample in 2013 was
about 17% [202]. Only about 10-20% of patients have access their health personal health
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records as at 2015 [34], [193], [205]. Most of the active users of PHR are younger,
Caucasians and of higher socio-economic status, however patients with chronic illness
who are of lower socio-economic status have reported more benefits from the using the
personal health record [194].
Benefits of the patient portal
The patient portal is a convenient and time saving tool for patients when making
appointments, referrals, requesting for refill of medications, communicating with their
healthcare provider and serve as a bridge for continuous interaction with the health
system beyond the clinic or hospital visit [47], [203], [205], [206]. Some studies have
shown improvement in management of chronic disease in patients using the portal [205],
[207], [208]. Kaiser Permanente recorded up to 6.5% improvement in the management
of chronic diseases with the portal, however, the specific mechanism responsible for the
improved outcome remains unclear [205], [208].
Summary
The patient-doctor relationship has evolved over the years from an acceptable
physician driven relationship to the current phase of increased advocacy for patient
centered care. The advocacy for SDM stems from equity and the outcomes of treatment
that occurs when both the physician and patient are involved in the treatment decision
making process. The President’s Commission initiated this advocacy in the early 80’s and
more recently, the Affordable Care Act has several provisions supporting a collaborative
clinical decision style. Several US health policy researchers believe that shared decision
making is one of the top ten elements to guide the redesign of health care in the United
States[10][72][73]. More specifically, they believe that shared decision making would
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lead to a decrease in variation in practice, decreased healthcare costs, decreased use of
invasive procedures, and increased quality of care [6], [7], [24], [72]–[76].
SDM has been described as a communication process [17], [18], a patient
empowering system [81], [83], the physician as a guide or friend [81], [83], division of
labor [84], and a process of using evidence based information in implementing patients’
treatment preferences [10]. SDM can be practiced across multiple clinical settings
ranging from the critically ill comatose patient in the ICU to the healthy patient who
requires a screening exam during routine primary care visits.
SDM process has three main components: information sharing, deliberation and
decision making. Patients participate in SDM at varying levels: some patients may prefer
to share information and deliberate but leave the final decision making to the provider
while others prefer to participate in the three phases of SDM [98]–[100], [126]. Health
status, gender, level of education, immigrant status, and ethnicity are some of the patient
factors that influence clinical decision style [19], [30], [98], [139]. On the other hand,
time during the clinical encounter, the physician’s training, practice volume,
communication skills, and infrastructure are some of the factors influencing a physician’s
decision-making style.
For patients to practice SDM, they need to be able to communicate with the
physician to understand and share relevant information, have access to information and
be able to negotiate decisions and give feedback to their providers.
The patient portal of an EHR provides a platform where patients can access their
health information and maintain continuous interaction with their healthcare provider
beyond the office visit. Additionally, the patient portal helps the patient overcome the
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issue of time constraints during the clinical visit as it provides a platform to communicate
with their providers beyond the scheduled time allocated to the patient during their visit.

Information
sharing

Deliberation

Access to medical
information & secure
messaging system

Decision
Making

Secure messaging
system

Patient Portal

Figure 2.1: Conceptual framework of the association between the portal use and SDM
Despite the potential benefits of the patient portal, there are no studies that
explicitly describe the relationship between accessing and utilizing the patient portal and
patient’s involvement in SDM. In this study, we will examine the relationship between
utilizing the patient portal and the different components of SDM.
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CHAPTER 3
METHODS
This chapter presents the research methodology used to assess the association
between patients’ access to their EHR patient portal and their involvement in shared
decision making. The first section presents the theoretical and conceptual framework
employed in designing this study’s empirical strategy. The theoretical framework chosen
from this study was informed by the literature review in the previous chapter. The next
section describes a broad overview of the aims and research questions as well as variables
used to measure the research questions. Next to the theoretical framework section is the
section that describes the data set and study population, and the last section shows the
data analytical methods used to achieve each of the study’s aims. The two specific aims
of this study are:
1. To describe the characteristics of patients who use the EHR patient portal
2. To determine the relationship between portal utilization and participation in SDM
This study used a cross-sectional retrospective research design to investigate the
relationship between patient portal usage and the components of shared decision making
(information sharing, deliberation, and decision making).
Theory and Research Conceptual Framework
This study was guided by the Donabedian’s quality assessment approach of
medical care (referred to as Donabedian model) and the Andersen Behavioral model of
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health service use (referred to as Andersen model) [141], [209]. The Donabedian model
adequately explains all 3 components of shared decision making (information sharing,
deliberation and decision making) while the Andersen model provides more insight on
the appropriate variables to measure the characteristics of the patients and the healthcare
setting where care is provided.
Donabedian Model: Structure, Process and Outcome in assessing the relationship
between the patient portal and SDM
The Donabedian quality assessment approach evaluates the quality of medical
care at the level of the patient-provider interaction [141]. Donabedian believed that the
interpersonal relationship between the patient and provider provides a scaffold for the
implementation of the more technical aspects of medical care. The Donabedian model
has three main constructs: structure (antecedents of care), process and outcome. Health
service assessment can be done at any of these levels. Evaluating the antecedents of care
gives the researcher a better understanding of the settings where care is being provided,
process of care shows that the acceptable and available standards of care are being
applied, and outcomes provides a precise measure of the effect of the intervention [141],
[210]. However, evaluating all three aspects: structure (antecedents), process and
outcome, provides a broader view of all the factors that influence the quality of care and
the areas that require improvement [210].
1.

Structure
Structure refers to the setting where care is being provided and all the resources

and factors that influence the process of receiving and providing care. Human resources,
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material resources and organizational setting are examples of structure. Specifically, in
this study the ‘structures’ are portal access, internet access, health insurance status and
having a regular source of care.
2.

Process
Process can be described as the events that occur during the delivery of health

care. This includes the activities carried out by the patient and provider in seeking and
providing care. Examples of process include communication and interpersonal
relationships between the patient and provider, and services provided in diagnosing and
treating the patient.
Information sharing and deliberation components of SDM can be described as the
SDM ‘process’. In this study, information sharing was measured with the following
survey questions: In the last 12 months how often did your healthcare providers explain
things in a way you could understand and give you the chance to ask all the health-related
questions you had. Deliberation was measured with the survey questions: In the last 12
months how often did your healthcare providers give the attention you needed to your
feelings and emotions, help you deal with feelings of uncertainty about your health or
health care, make sure you understood the things you needed to do to take care of your
health, and spend enough time with you.The survey questions were in a Likert scale with
4 measures: Always, usually, sometimes and never with “always” given a measure of 1
and “never” given a measure of 4.
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3.

Outcome
Outcomes refers to the overall effect of care on the patient as an individual and

the community at large. Examples of outcome include health status, knowledge, and
satisfaction of the patient. In this study, the outcome is decision making which is one of
the components of SDM. Decision making was measured as ‘During the last 12 months,
how often were you involved in decisions about your health care as much as you
wanted?’. The survey question was in a Likert scale with 4 measures: Always, usually,
sometimes and never with “always” given a measure of 1 and “never” given a measure of
4.
The SDM process and outcomes will be measured from patient’s perspective.
Focusing on patient’s perspective is important, because research shows that there is a
discrepancy between patient reported and provider reported implementation of SDM with
physicians reporting a higher rate of involvement in SDM compared to patients [154].
Additionally, Charles et al believe that the patient’s preference and perception of
involvement in the process is the most relevant measure of SDM [17].
Andersen: Predisposing, Enabling and Need factors in assessing the relationship
between the patient portal and SDM
To further understand the relationship between the patient portal and SDM, we
applied the Andersen model of healthcare utilization to determine some characteristics
that may predispose patients to use the portal and participate in SDM. The Andersen
model was designed to explain and predict how individuals use health services[209].
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The constructs of the model are: 1) predisposing factors which refers to biological
and social factors directly related to the individual and the health system that incline them
to utilize the health system [209], [211]. Predisposing factors include demographic and
social factors as well as health beliefs [209], [211], 2) enabling factors refers to processes
or resources required for the utilization of health service [209], [211] and 3) the need for
care which could be perceived or evaluated [209], [211]. The predisposing, enabling and
need factors influence utilization of the patient portal as well as SDM.

Structure

Predisposing Factors
Enabling Factors

Process

Information
sharing

Outcome

Deliberation

Decision Making
Health status
Quality of care

Need

Access to medical info & Secure
messaging
(Patient Portal)

Figure 3.1: Conceptual framework using Donabedian and Andersen theories
The predisposing factors in this study are: age, gender, race, marital status,
education attainment, immigrant status, and fluency in English language. Age, gender,
race, marital status and education attainment are demographic characteristics and can be
clearly identified as predisposing characteristics based on Andersen model. However,
with regards to SDM and the patient portal of an EHR, immigrant status, and fluency in
English were included in this study because these variables could influence involvement
in health care decision making and portal utilization.
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The enabling factors in this study are: income, portal access, internet access,
health insurance status and having a regular source of care and being encouraged to use
the portal. Some of the enabling factors are related to the structure component of the
Donabedian model. Portal access, internet access, health insurance status and having a
regular source of care can be described as components of structure.
The last component of the Andersen model is need factors. The need factors in
this study are: chronic diseases and preference sensitive conditions. The chronic diseases
include diabetes, hypertension, heart condition, lung disease and depression and the
preference sensitive conditions are breast cancer, prostate cancer, and rheumatism.
Dataset and study population
The dataset for this study was obtained from the Health Information National
Trends Survey (HINTS) which is administered by the National Cancer Institute [54]. It is
a cross-sectional nationally representative dataset of adults 18 years and above collected
via mailed self-administered questionnaire. The survey is done periodically
approximately every 1-2 years[54]. The first survey was administered in 2003 and the
survey used for this study in 2017. The dataset contains information on cancer prevalence
and treatment, nutrition, health communication trends and practices, and health
information technology access and use [54]. The data received a full-sample weight and a
set of 50 replicate weights to ensure it is nationally representative [54].
For this study, we used the data set: HINTS 5 (Cycle 1). The HINTS 5 (Cycle 1)
version has questions related to portal adoption rate and contains questions that measure
the different components of SDM [54]. The data was collected between January 25 and
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May 5, 2017 and has a total sample size of 3,285 respondents. We excluded participants
who had no access to the internet and the portal as well as those who did not complete all
the survey questions.
1. Aims, Research Questions and Survey Variables
Aim 1: To describe the characteristics of patients who use the EHR patient portal
R1: What are the characteristics of the patients who use the EHR patient portal?
Independent Variable: Frequency of portal utilization.
HINTS Survey Question to Define Independent Variable: How many times did you
access your online medical record in the last 12 months?
Dependent Variables: SDM components (Information sharing, deliberation, and
decision making).
HINTS Survey Question to Define Dependent Variables:
1. SDM Information Sharing
i.

In the last 12 months how often did your healthcare providers explain
things in a way you could understand

ii.

In the last 12 months how often did your healthcare providers give you the
chance to ask all the health-related questions you had

2. SDM Deliberation
i.

In the last 12 months how often did your healthcare providers give the
attention you needed to your feelings and emotions
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ii.

In the last 12 months how often did your healthcare providers make
sure you understood the things you needed to do to take care of your
health

iii.

In the last 12 months how often did your healthcare providers spend
enough time with you

iv.

In the last 12 months how often did your healthcare providers help you
deal with feelings of uncertainty about your health or health care

3. SDM Decision Making
i.

In the last 12 months how often did your healthcare providers involve
you in decisions about your health care as much as you wanted

Other Independent Variables based on the Andersen healthcare utilization model
▪

Predisposing Factors: age, gender, race, marital status, education
attainment, immigrant status, and fluency in English language

▪

Enabling Factors: income, health insurance status, having a regular source
of care, being encouraged to use the portal

▪

Need Factors: chronic disease such as diabetes, hypertension, heart
condition, lung disease and depression; and preference sensitive condition
(breast cancer, prostate cancer, rheumatism)

Aim 2: To determine the relationship between portal utilization and participation in SDM
R2: What is the association between portal utilization and SDM?
Independent Variable: Frequency of portal utilization (see R1 for defining questions)
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Dependent Variables: SDM components (Information sharing, deliberation, and
decision making) (see R1 for defining questions)
Other Independent Variables based on the Andersen healthcare utilization model
▪

Predisposing Factors: age, gender, race, marital status, education
attainment, immigrant status, and fluency in English language

▪

Enabling Factors: income, health insurance status, having a regular source
of care, being encouraged to use the portal

▪

Need Factors: chronic disease such as diabetes, hypertension, heart
condition, lung disease and depression; and preference sensitive condition
(breast cancer, prostate cancer, rheumatism)

R3: What is the association between portal utilization and participation in SDM among
people with a chronic disease or preference sensitive condition?
Population: People who have access to the internet, have been given access to the portal,
and have at least one chronic disease or one preference sensitive condition.
HINTs Survey Question used to Narrow Population to a specific condition:
1. Has a doctor or other health professional ever told you that you had any of the
following medical conditions: (diabetes, hypertension, heart condition, lung
disease and depression); and preference sensitive condition (Breast cancer,
prostate cancer, Rheumatism)
Independent Variable: Frequency of portal utilization (see R1 for defining questions)
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Dependent Variables: SDM components (Information sharing, deliberation, and
decision making) (see R1 for defining questions)
Other Independent Variables based on the Andersen healthcare utilization model
▪

Predisposing Factors: age, gender, race, marital status, education
attainment, immigrant status, and fluency in English language

▪

Enabling Factors: income, health insurance status, having a regular source
of care, being encouraged to use the portal

▪

Need Factors: chronic disease such as diabetes, hypertension, heart
condition, lung disease and depression; and preference sensitive condition
(breast cancer, prostate cancer, rheumatism)

2. Data analytical methods
Data analysis for this study was done using SAS 9.4 [212]. Descriptive statistics
for the mean, standard deviation, and percentages or tabulations for count variables was
performed. Further analysis was based on the specific aims and research questions. Each
specific aim is accompanied by a research question or questions, beneath which the
specific analytical methods for that aim is specified.
Aim 1: To describe the characteristics of patients who use the EHR patient portal
R1: What are the characteristics of patients who use the EHR patient portal?
We determined the percentages, mean and standard deviations of the study
population by examining the age, gender, race, marital status, education attainment,
immigrant status, and fluency in English language, income, health insurance status,
having a regular source of care, being encouraged to use the portal, chronic disease (such
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as diabetes, hypertension, heart condition, lung disease and depression); and preference
sensitive condition (breast cancer, prostate cancer, rheumatism). Additionally, we
measured the mean, standard deviations and confidence intervals for the different
components of SDM (Information sharing, deliberation, and decision making). For each
component of SDM, we merged the survey questions to create a single variable for SDM
Information Sharing.
The percentages, mean and standard deviations were measured for the whole
study population and for two subsets of the population: those who have used the portal at
least once and those who have access but did not use the portal.
Aim 2: To determine the relationship between portal utilization and participation in SDM
R2: What is the association between portal utilization and SDM
Independent Variable: Frequency of portal utilization. Dependent Variables: SDM
components (Information sharing, deliberation, and decision making). Control Variables:
Predisposing, enabling and need factors based on the Andersen healthcare utilization
model
The HINTS 5 Cycle 1 data set has questions measuring Information Sharing and
Deliberation components of SDM. For each component of SDM, we assessed for
reliability between the questions using Cronbach’s Alpha and then merged the survey
questions to create a single variable. They survey questions are in a Likert scale from 1-4,
with four as never and I as always. The survey questions had internal reliability, so the
responses were dichotomized to create variables using a top box scoring approach where
only the highest possible score was considered SDM [213], [214]. Respondents who
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answered Always to all the SDM questions were categorized as ‘yes’ and all other
responses on the Likert scale (usually, sometimes and never) were categorized as ‘no’.
To determine the association between portal utilization and participation in SDM,
we ran a bivariate analysis. Then, we ran three ordinal regression models to measure the
association in each component of SDM.
The regression model for each component is below:
SDM-information sharing = ß0+ ß1predisposing factors +ß2enabling factors
+ß3need factors
SDM-Deliberation = ß0+ß1 predisposing factors + ß2enabling factors + ß3need
factors
SDM- Decision Making = ß0+ß1 predisposing factors + ß2 enabling factors +
ß3need factors
R3: What is the association between portal utilization and participation in SDM
among people with a chronic disease or preference sensitive condition?
Population: People who have access to the internet, have been given access to the
portal, and have at least one chronic disease or one preference sensitive condition.
To determine the association between portal utilization and participation in SDM,
we ran a bivariate analysis. Then, ran three ordinal regression models to measure the
association in each component of SDM.
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The regression model for each component is below:
SDM-information sharing = ß0+ ß1predisposing factors +ß2enabling factors
SDM-Deliberation = ß0+ß1 predisposing factors + ß2enabling factors
SDM- Decision Making = ß0+ß1 predisposing factors + ß2 enabling factors
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CHAPTER 4
RESULTS
The HINTS 5 Cycle 1 dataset contained 3,285 respondents. However, some
respondents who had responses that were inappropriate to the questions or who did not
meet the inclusion criteria were excluded from the analytical dataset. Participants were
excluded for the following reasons: no internet access, no portal access and missing
information on SDM components, age, gender, race, marital status, education, income,
regular provider, encouraged to use portal, chronic disease, portal access (Figure 4.1).
People without portal access were excluded from the study because the main independent
variable in this study is portal access. In addition, respondents without internet access
were excluded from the study because the only way to access the portal is through the
internet. Lastly, participants with item non-response were excluded from the study after
assessing that they were missing completely at random. After these exclusions, the final
sample size became 1,198. The dataset was weighted to be nationally representative with
an estimated population size of 88,979,991[54].
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Total Study Population = 3285

Excluded the following people (n= 2,087)
•
•
•
•
•
•

•
•

New Study Population = 1198

Without internet access (n=752)
Without portal access (n=1093)
Missing response to SDM
components (n=123)
Missing response to
Demographics(n=99)
Missing response to Regular
Provider (n=2)
Missing response to Encouraged to
portal (n=2)
Missing response to Chronic disease
(n=6)
Missing response frequency of
accessing portal (n=10)

Demographics= Age, Gender, Race, Marital
Status, Education, Income, Insurance

Figure 4.1: Flow Chart of HINTS Cycle 5 Participants selection
Table 4.1 compares the final study population and the participants excluded from the
study on key demographics such as age gender, race, marital status, education, immigrant
status and income. The mean age was similar for both groups, there were more females,
more Caucasians and less minority groups, more married people, more college graduates,
more non-immigrants and higher income earners in the study population compared to the
excluded population. The demographic distribution of the final study population bears
closer semblance to the gender and racial distribution in the US with a higher percentage
of females compared to males above 18 years of age and more Caucasians compared to
other races [215].
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Table 4.1: Demographic characteristics of survey population
Variable

Age, mean (SD)

Final Study

Excluded

Population %

Population %

n=1198

n=2087

46

45

Male

42.5

47.9

Female

57.5

42.5

Missing

-

9.6

Caucasian

73.4

53.0

African American

9.4

9.5

Others

17.2

24.8

Missing

-

12.7

Married

64.2

47.9

Divorced/widowed/separated

9.8

16.8

Single

26.0

31.2

-

4.1

High School or less

20.4

36.9

Some College

34.2

31.0

College Graduate or more

45.4

28.9

-

3.2

Non-immigrant

88.5

81.8

Immigrant

11.5

16.6

Missing

-

2.6

<$35,000

18.0

36.2

Gender,

Race,

Marital status,

Missing
Education,

Missing
Immigrant Status,

Income,
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$35,000 - <$75,000

32.0

35.0

≥$75,000

50.0

27.1

Missing

-

1.7

Yes

95.8

87.7

No

4.2

10.4

-

1.9

Insurance,

Missing

Internal reliability for measures of SDM
The main dependent variable in this study is SDM which we separated into 3
components which are information sharing, deliberation and decision making.
Information sharing and deliberation were measured with two and four survey questions
respectively, hence we had to evaluate for internal reliability among between the
questions measuring each component.
The HINTS dataset measured the components of SDM in a Likert Scale. We
dichotomized SDM into a binary variable using a top box scoring approach where only
the highest possible score was considered SDM [213], [214]. Respondents who answered
Always to participating in SDM were categorized as ‘yes’ and all other responses on the
Likert scale (usually, sometimes and never) were categorized as ‘no’.
Two survey questions measured Information Sharing. Both questions had a high
internal reliability with an alpha coefficient of 0.7. Deliberation was measured with four
survey questions and the alpha coefficients of the four questions was 0.9. Decisionmaking was measured with a single survey question so did not require measurement of
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internal reliability. The internal reliability of all the survey questions (seven questions)
measuring each component of SDM was 0.9.
To further explain the relationship between portal usage and components of SDM,
we included factors that may predispose, enable and make a patient need to use the portal
based on Andersen theory of health utilization to adjust for differences in participation in
SDM. The predisposing factors in this study are: age, gender, race, marital status,
education attainment, immigrant status, and fluency in English language. Fluency in
English was taken out of the model because immigrant status can be used as a proxy for
fluency in English. In addition, there were 27 missing responses to fluency in English
while immigrant status had a complete response rate in our study population. Using
fluency in English would further reduce our sample size hence its elimination from our
dependent variables/predisposing factors. The enabling factors in this study are:
frequency of portal utilization, income, health insurance status and having a regular
source of care and being encouraged to use the portal. The last component of the
Andersen model is need factors. The need factors in this study are: chronic diseases and
preference sensitive conditions. The chronic diseases include diabetes, hypertension,
heart condition, lung disease and depression and the preference sensitive conditions are
breast cancer, prostate cancer, and rheumatism.
Aim 1: To describe the characteristics of patients who use the EHR patient portal
▪

R1: What are the characteristics of the patients who use the EHR patient portal?

Table 4.2 shows information on the characteristics of study participants by portal
utilization. The percentages, mean and standard deviations of the predisposing, enabling
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and need factors were calculated for the whole study population and for two subsets of
the population: those who have used the portal at least once and those who have access
but did not use the portal.
Table 4.2 Baseline Characteristics of study participants by portal utilization
Characteristics

Total Study

SE

Portal

SE

Population,

utilizers,

1

2

% n=1198

%n=748

Non-

SE

p-value

utilizers, %
n=4503

Predisposing Factors
46a(0.6)

0.6

Male

42.5

2.0

Female

57.5

Caucasian

3.4

1.7

72.2

2.2

African American

9.4

1.0

8.5

Others

7.2

1.6

Married

4.2

D/W/S4

Age, mean (SD)

47 a(0.9)

0.9

46 a(1.7)

1.7

Gender,
40.7

2.6

4.1

0.4006

75.2

3.0

0.2293

1.2

10.6

1.7

19.3

2.2

14.2

2.5

1.9

67.0

2.6

60.0

4.6

9.8

0.8

10.0

1.3

9.6

1.4

Single

26.0

2.1

23.0

2.7

30.4

5.1

≤ High School

20.4

2.1

15.3

2.4

28.1

4.1

Some College

34.2

2.0

31.8

2.1

37.7

4.5

≥ College Degree

45.4

2.3

52.9

2.7

34.2

3.7

Non-immigrant

88.5

1.6

87.3

1.9

90.2

2.7

Immigrant

11.5

59.3

45.2
54.8

Race,

Marital status,
0.3156

Education,
0.0008

Immigrant Status,

12.7

Enabling Factors
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9.8

0.6701

Freq of portal
utilization,
0

40.3

2.6

-

100

1-2 times

30.5

2.0

51.2

2.8

-

3-5 times

18.1

1.9

30.3

2.7

-

>5 times

11.1

1.2

18.5

2.0

-

<$35,000

18.0

2.1

15.3

2.5

22.2

3.9

$35,000-<$75,000

32.0

2.6

28.9

2.4

36.4

5.4

≥$75,000

50.0

2.4

55.8

2.8

41.4

3.9

Yes

95.8

1.5

97.6

1.7

93.2

No

4.2

Yes

78.1

No

21.9

Income,
0.0339

Insurance, †

2.4

3.2

0.2216

6.8

PCP,
2.3

84.6

1.9

15.4

68.5

5.2

0.0013

3.8

<.0001

4.7

0.4646

31.5

Encouraged to use
the portal,
Yes

70.0

No

30.0

2.2

83.2

2.3

16.8

50.5
49.5

Need Factors
Chronic disease,
Yes

60.5

No

39.5

2.6

62.1

3.0

37.9

58.2
41.8

Preference
sensitive condition,

a

Yes

23.1

No

76.9

1.4

25.5
74.5

2.3

19.6

2.2

0.0954

80.4

= mean age ; Weighted value for total population (n= 88,979,991)1; Weighted

value for portal utilizers (n= 53,081,874) 2; Weighted value for nonportal utilizers (n=
35,898,117) 3; 4= Divorced/Widowed/Separated; †The estimates of the proportion of
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folks without health insurance may be unreliable because the number of people without
health insurance is less than 30 and may be too small to yield stable estimates.
Most portal utilizers were female (59%), married (67%), Caucasians (72%), had a
college degree or more (53%), were US born (87%) with a mean age of 46 years. Over
50% of the population used the portal about 1 to 2 times. A large proportion earned more
than $75,000 (55.8%), had insurance coverage (98%), had a regular provider (85%) and
were encouraged to use the portal by their health care providers (83%). In addition, more
than half of the population of portal utilizers had at least one chronic (62%) and about a
quarter had a preference sensitive condition (25.5%).
The predisposing, enabling and need factors were not significantly different
between portal and non-portal utilizers (p >0.05) except for education attainment,
income, having a PCP and being encouraged to use the portal. Portal utilizers had more
college degrees (53% vs 34%, p <0.0008), had a higher proportion of people in the higher
income bracket (56% vs 41%, p <0.0339), had a regular provider (85% vs 69%, p
<0.0013), and were more likely to have been encouraged to use the portal (83% vs 51%,
p<0.0001).
We decided to exclude insurance coverage in further analysis because so few
people lack health insurance and the number of people without insurance would be too
small to provide reliable regression estimates.
Aim 2: To determine the relationship between portal utilization and participation in SDM
The second aim of our study was to assess if there was a relationship between
portal utilization and components of shared decision making. We hypothesized that there
is a relationship between portal utilization and components of shared decision making.
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We also created a subpopulation of participants who had at least one chronic disease or
preference sensitive condition because of increased contact with the health system
required for patients with chronic disease and the multiple viable treatment options that
exists for these conditions.
Our descriptive statistics in Table 4.2 showed that about 56% of the total study
population participated in information sharing, 37% deliberation and 55% in decision
making. There was no statistically significant difference in participation in any of the
components of SDM between portal utilizers and non-portal utilizers.
In addition, our bivariate analysis did not show any significant relationship
between our main dependent variable, portal utilization and any of the components of
SDM. However, some of the other dependent variables had a significant relationship with
components of SDM.
The tables below (Tables 3-5) shows the association between portal use, gender,
race, age, marital status, educational attainment, immigration status, income, having a
PCP, being encouraged to use the portal, presence of a chronic disease and presence of a
preference sensitive condition and information sharing, deliberation and decision making.
There was a significant association between educational attainment (p=0.0222) as
well as immigrant immigration status (p=0.0018) and Information sharing (Table 4.3).
Bivariate analysis for deliberation also revealed a similar pattern with a significant
association between educational attainment (p=0.009) as well as immigrant immigration
status (p=0.0021) and deliberation (Table 4.4). Only immigration status (p =0.0001) was
significantly associated with decision making (Table 4.5).
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Table 4.3: Bivariate results for information sharing
Information sharing (n =1198)1

Portal use, %2

All

Yes

No

0 times

40.3

38.5

42.6

1-2 times

30.5

31.8

28.9

3- 5 times

18.1

19.6

16.1

>5 times

11.1

10.0

12.3

Male

42.5

42.5

42.6

Female

57.5

57.5

57.4

White

73.4

75.0

71.4

Black

9.4

8.3

10.7

Others

17.2

16.7

17.9

46.5

46.6

46.3

64.2

64.9

63.4

D/W/S4

9.8

10.1

9.4

Single

26.0

25.0

27.2

p value3

0.4499

Gender, %2

0.9893
Race, %2

Age, mean (SD)
Marital Status, %2

Married

Education

High school or less

20.4

16.0

26.0

Attainment, %2

Some college

34.2

38.5

28.9

College or more

45.3

45.5

45.2

Yes

88.5

92.5

83.5

(Born in the US)

No

11.5

7.5

16.5

Income, %2

< $35,000

18.1

14.5

22.5

$35,000- < $75,000

32.0

33.6

29.9

≥$75,000

50.0

51.9

47.6

Yes

78.1

78.7

77.3

No

21.9

21.3

22.7

Encouraged to use

Yes

70.0

69.4

70.7

the portal, %2

No

30.0

30.6

29.3

Chronic disease, %2

Yes

60.5

60.9

60.1

No

39.5

39.1

39.9

Yes

76.9

76.5

77.3

No

23.1

23.5

22.7

Immigrant

status,

PCP, %2

0.5070

0.8720

0.8960

0.0222

0.0018

0.0879

0.7533

0.8212

0.8932
Preference Sensitive
condition, %
1

2

0.8383

unweighted sample size; 2Weighted percentages; 3p values derived from Chi square test

for categorical variables.4Divorced/widowed/separated
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Table 4.4: Bivariate results for deliberation
Deliberation (n =1198)1
All

Yes

No

0 times

40.3

40.8

40.1

1-2 times

30.5

32.0

29.7

3- 5 times

18.1

16.4

19.0

>5 times

11.1

10.8

11.2

Male

42.5

43.5

42.0

Female

57.5

56.5

58.0

White

73.4

75.1

72.4

Black

9.4

8.2

10.1

Others

17.2

16.7

17.6

(mean age diff)

46.5

45.6

47.0

64.2

62.4

65.3

D/W/S4

9.8

9.8

9.8

Single

26.0

27.8

24.9

20.4

16.5

22.8

34.2

43.3

28.8

45.3

40.2

48.4

Yes

88.5

93.9

85.3

%

No

11.5

6.1

14.7

Income, %2

< $35,000

18.1

13.6

20.7

$35,00- < $75,000

32.0

31.8

32.0

≥$75,000

50.0

54.6

47.3

Yes

78.1

76.7

78.9

No

21.9

23.3

21.1

Encouraged to use

Yes

70.0

69.3

70.4

the portal, %2

No

30.0

30.7

29.6

Chronic disease, %2

Yes

60.5

58.9

61.5

No

39.5

41.1

38.5

Yes

76.9

79.0

75.6

No

23.1

21.0

24.4

Portal use, %2

p value3

0.8933

Gender, %2

0.8096
Race, %2

Age, mean (SD)
Marital Status, %2

Education

Married

High school or less

Attainment, %2

Some college
College or more

Immigrant

status,

0.6368

0.5349

0.859

0.009

0. 0021

2

PCP, %2

0.2111

0.7054

Preference Sensitive
condition, %

2

0.8594

89

0.706
0.3852

1

unweighted sample size; 2weighted percentages; 3p values derived from Chi

square test for categorical variables. 4Divorced/widowed/separated
Table 4.5: Bivariate results for decision making
Decision Making (n =1198)1

Portal use, %

All

Yes

No

0 times

40.3

39.7

41.1

1-2 times

30.5

31.3

29.7

3- 5 times

18.1

18.2

17.9

>5 times

11.1

10.8

11.3

Male

42.5

43.6

41.2

Female

57.5

56.4

58.8

White

73.4

75.4

71.0

Black

9.4

8.5

10.4

Others

17.2

16.1

18.6

(mean age diff)

46.5

47.0

45.8

64.2

64.0

64.4

D/W/S4

9.8

10.6

8.8

Single

26.0

25.3

26.7

High school or less

20.4

18.0

23.4

34.2

38.2

29.3

45.3

43.8

47.3

p value3

0.9816

Gender, %

0.6611
Race, %

Age, mean (SD)
Marital Status,
%

Education
Attainment, %

Married

Some college
College or more

Immigrant

Yes

88.5

93.3

82.6

status, %

No

11.5

6.7

17.4

Income, %

< $35,000

18.1

15.1

32.0

32.8

≥$75,000

50.0

52.1

Yes

95.8

95.3

96.4

No

4.2

4.7

3.6

Yes

78.1

79.9

75.8

No

21.9

20.1

24.2

Encouraged to

Yes

70.0

68.5

71.9

use the portal,

No

30.0

31.5

28.1

$35,00- < $75,000

Health
insurance

0. 3367

0.5364

0.8447

0.1523

0.0001

0.1978

0.7200

status, %
PCP, %

0.4259

%

90

0.5404

Chronic

Yes

60.5

58.6

62.9

disease, %

No

39.5

41.4

37.1

Preference

Yes

76.9

77.4

76.2

Sensitive

No

23.1

22.6

23.8

0.4466

0.7736

condition, %

1

unweighted sample size; 2weighted percentages; 3p values derived from Chi

square test for categorical variables. 4Divorced/widowed/separated
Table 4.6 shows the results for the multivariable logistic regression analyses
looking at factors that are associated with each component of shared decision-making:
information sharing, deliberation and decision making.
Some college education was statistically significantly associated with information
sharing and deliberation, and immigration status was associated with all components of
SDM. Compared to people with high school degree, people with some college degree had
2 times the odds of sharing information and deliberating with their healthcare providers
(information OR =2.1, CI=1.0-4.3; deliberation OR=2.0, CI=1.0-4.0). Immigrants had
60% less odds of participating in information sharing (OR=0.4, CI = 0.2 – 0.8) and 70%
less odds of being engaged in deliberation (OR=0.4 CI=0.2-0.9) and decision making
(OR=0.3 CI =0.1 – 0.8) respectively when compared to non-immigrants. Portal use,
gender, race, insurance status and having a preference sensitive condition were not
significantly associated with any of the components of shared decision making.
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Table 4.6: Association between portal utilization and SDM (n =1198)1
R2: What is the association between portal utilization and SDM?
Information Sharing
OR

95%CI

Deliberation
OR

95%CI

OR

95%CI

Access online

0 times

Ref

record

1-2 times

1.2

0.7 - 2.0

1.1

0.7-1.7

1.1

0.7- 1.9

3-5 times

1.4

0.7 - 2.6

0.9

0.4-1.8

1.1

0.6- 2.1

>5 times

0.8

0.4 - 1.5

0.9

0.5-1.8

1.0

0.5-1.9

Male

Ref

Female

0.9

White

Ref

Black

0.9

0.5-1.5

1.1

0.6-1.9

1.0

0.6-1.5

Others

1.2

0.7-2.1

1.3

0.8-2.1

1.2

0.7-2.0

1.0

1.0-1.0

1.0

1.0-1.0

1.0

1.0-1.0

Gender

Race

Age
Marital Status

Ref

Decision Making

Ref

Ref
0.6-1.5

0.9

Ref
0.6 - 1.5

Ref

0.9

0.6-1.3

Ref

Married

Ref

D/W/S

1.1

0.7-2.0

1.3

0.7-2.3

1.3

0.8-2.1

Single

0.9

0.5-1.6

1.2

0.6-2.4

1.0

0.5-2.1

Education

High

Attainment

school or
less

Ref

Ref

Ref

Ref

Ref

Some
college

2.1

1.0-4.3

2.0

1.0-4.0

1.6

0.7-3.4

more

1.7

0.9-3.1

1.0

0.5-2.0

1.2

0.6-2.3

Immigrant

Yes

Ref

status

No

0.4

College or

Income

Ref
0.2-0.8

0.4

Ref
0.2-0.9

0.3

0.1-0.8

<
$35,000

Ref

Ref

Ref

$35,00-<

PCP

$75,000

1.6

0.8-3.2

1.5

0.6-3.5

1.4

0.7-2.8

≥$75,000

1.5

0.7-3.1

1.9

0.9-4.2

1.5

0.7-3.1

Yes

Ref

No

1.0

Yes

Ref

Ref
0.6-1.7

1.1
Ref
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Ref
0.6-2.1

0.8
Ref

0.4-1.6

Encouraged

No

1.2

Chronic

Yes

Ref

disease

No

0.9

PSC

Yes

Ref

No

0.9

0.7-2.1

1.0

0.6-1.6

1.2

0.7-2.0

to use the
portal
Ref
0.6-1.4

Ref

1.1

0.6-1.9

Ref
0.6-1.3

1.3
Ref

1.1

0.7-1.7

1.0

0.8-2.2

0.6-1.7

D/W/S= Divorced/ Widowed/ Separated, PSC= Preference sensitive condition;
1

unweighted population, ref= reference
Table 4.7 shows the results of the regression analysis measuring components of

shared decision making among patients with at least one chronic disease or preference
sensitive conditions. Participants with some college education had 2.3 times the odds of
engaging in information sharing (OR=2.5; CI= 1.1 – 4.9) compared to those with high
school education. In addition, minority racial groups categorized as ‘others’ had 1.7 times
the odds of participating in deliberation (OR=1.7, CI=1.0- 3.0) compared to Caucasians.
All other variables did not show any statistically significant association with any of the
shared decision-making domains.
Table 4.7: Association of portal utilization and participation in SDM in participants with
chronic disease / preference sensitive conditions (n= 843)1
R3: What is the association between portal utilization and
participation in SDM among people with a chronic disease or
preference sensitive condition?
Information

Deliberation

Decision Making

OR

OR

Sharing
OR

95%CI

95%CI

Ref

95%CI

Access online

0 times

Ref

record

1-2 times

1.1

0.6-2.1

0.8

0.4-1.4

1.0

0.5-2.0

3- 5 times

1.1

0.5-2.1

0.8

0.4-1.8

1.0

0.5-2.1

>5 times

0.6

0.3-1.1

0.7

0.3-1.2

0.8

0.4-1.7
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Ref

Gender

Race

Male

Ref

Female

0.9

White

Ref

Black

0.7

0.3-1.3

0.8

0.4-1.5

0.7

0.4-1.4

Others

1.0

0.5-2.2

1.7

1.0-3.0

1.4

0.7-2.6

1.0

1.0-1.0

1.0

1.0-1.0

1.0

1.0-1.0

Age
Marital
Status

Married
D/W/S
Single

Ref
0.6-1.4

1.2

Ref
0.7-1.9

Ref

Ref
0.6-2.0

0.9

0.4-2.0

1.1
0.8

0.7-1.7

Ref

Ref

1.1

1.1

Ref
0.6-2.0
0.3-1.9

Ref

1.2
1.0

0.7-2.1
0.4-2.1

Education

High school or less

Ref

Ref

Attainment

Some college

2.3

1.1-4.9

1.8

0.9-3.7

1.6

0.8-3.5

College or more

1.5

0.7-3.1

0.8

0.4-1.6

1.1

0.5-2.4

Immigrant

Yes

Ref

status

No

0.6

Income

< $35,000

Ref

$35,00- < $75,000

1.1

0.5-2.1

1.0

0.4-2.2

1.1

0.6-2.3

≥$75,000

1.2

0.5-2.8

1.6

0.6-3.7

1.4

0.6- 3.2

Yes

Ref

No

1.2

Encouraged

Yes

Ref

to use the

No

PCP

1.0

Ref
0.2-1.3

0.4

Ref
0.1-1.2

Ref

1.3

Ref
0.6-2.5

Ref
0.5-1.9

0.8

0.2-1.4

Ref

Ref
0.6-2.4

0.5

0.7

0.3-1.8

Ref
0.5-1.1

1.1

0.6-2.1

portal

1

unweighted population; D/W/S= divorced/widowed/separated; ref= reference
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CHAPTER 5
DISCUSSION
SDM has been strongly advocated as the most appropriate clinical decision
making model and several studies have focused on mechanisms of promoting SDM [19].
The patient portal of an EHR has been previously described to have the potential to
increase the physician patient relationship by providing information which could enable
the patient to participate in their healthcare [34]. In the United States, there has been
increased access to the portal because of the HITECH Act. The HITECH Act has
mandated providers to provide an electronic portal to patients where they can send secure
messages to their healthcare providers and view some of their health records online.
This study was designed to explore the relationship between the patient portal
utilization and SDM. SDM was evaluated for at the level of each component of SDM:
information sharing, deliberation and decision making and portal usage. This was a nonsignificant study based on my key variables of interest: portal utilization and components
of SDM.
The study results demonstrate that the patient portal is not associated with any
component of SDM. Our initial hypothesis was that the patient portal would have a
positive relationship with SDM because the portal contains details of the patient’s health
record and has a functionality which allows the patient to communicate directly with their
healthcare provider. However, the study result does not show a relationship between
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accessing the portal and participation in SDM, not even the information sharing
component of SDM. This demonstrates that having access to information does not
automatically enable the patient to participate in their clinical decision-making process. A
deliberate effort to empower the patient beyond just providing a portal is needed for SDM
to occur. Perhaps, the portal may enhance SDM when the patient has been empowered to
participate in their care. The findings from other variables controlled for in this study
further emphasizes this.
Our results showed that immigrants and people with high school education were
less inclined to participate in their health care process when compared to non-immigrants
and those with some college degree. Immigrant status was significantly associated with
less participation in all components of SDM among the entire study population. We can
infer from this finding that limited English proficiency may be the hinderance in the
immigrant population to participation in SDM[216]. Being able to articulate your
thoughts in clear language and being confident that you are being understood would
promote SDM between patients and their healthcare providers even if the provider is
paternalistic. In addition, studies have shown that physicians use a lot of medical jargon
in up to 80% of clinical encounters leading to a low patient comprehension of their health
situation. This may further create a communication gap between the patient and the
physician with the patient feeling less empowered[217], [218]. In addition, the
information in most portals is written in English and immigrants who do not read in
English will have problems comprehending the information in the portal without a
translator [219]. The portal can provide knowledge but if the patient lacks language skill
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to communicate their preferences, then knowledge alone will not be enough to stimulate a
patient to participate in their clinical decision.
Education was another significant independent variable, both in the whole study
population and the subset of participants with at least one chronic disease or preference
sensitive condition. Patients who had some college degree were more likely to be
involved in the information sharing and deliberation components of shared decision
making than those who had high school degree or less. It is noteworthy that only the
information sharing component of SDM had a relationship with education in patients
with a chronic disease or preference sensitive condition, meaning patients with chronic
disease and preference sensitive conditions who had some college degree, are more likely
to share information with their health care providers than those with a high school degree
or less education. However, there was no significant relationship between education and
deliberation and final decision making in this population. This finding is similar to a
previous study that showed that patients would rather have their physicians make
decisions when it involved complex medical conditions for example like Rheumatoid
arthritis which is a preference sensitive condition [30]. An explanation for this may be the
complexity involved in deliberating and finally choosing a treatment option in diseases
with multiple treatment options. The more complex the problem and treatment option, the
more likely the patient would defer to the physician to make the decision because the
patient feels uninformed and thus unempowered to participate in their care. In addition,
patients believe that the physician has more knowledge and experience and as such
knows best makes the patient succumb to a more paternalistic approach [14]. Another
study by J. Klein further supports this finding between education and decision making by
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demonstrating that formal education has an effect on linear decision making[219]. In this
context, that implies making decisions linearly from sharing information to deliberation
and then to the final decision making. Thus, patients with high school degree or less with
at least one chronic disease or preference sensitive conditions was more likely not to
participate in their clinical decision-making process.
The language skill and confidence are the common thread which ties immigrant
status and education level with information sharing and deliberation components of
SDM. People need to have a certain level of education and language skill to be confident
enough to express their thoughts and deliberate with their healthcare providers. Evidence
exists that there is increased patient satisfaction and compliance with treatment when they
are involved in their clinical decision making[30].
Study limitations
This study had several limitations. The first is the use of secondary data with
variables that were not designed primarily for this study. This created some restrictions
on the available variables based on the information collected.
Another limitation was the way data was grouped to have reliable estimates. For
example, Preference Sensitive conditions and chronic disease was grouped to be a single.
Probably a statistically significant difference could have been found for one chronic or
preference sensitive condition.
A third limitation is the use of only quantitative data in the study. Using a mixed
method examining both physician and patient’s perspective on portal utilization may
provide more insight on the relationship between portal utilization and SDM.
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In addition, technology adoption and maturity research show that as technology
matures its adoption rate increases. The adoption of the patient portal is currently low and
as the technology matures and become more adopted, future studies may find a
relationship between the patient portal and SDM.
Conclusion
This study demonstrated that increased access to patient’s information through a
portal is not associated with SDM. Although this study did not show a significant
relationship between portal utilization and SDM, it steered us towards what previous
authors have pointed out in the past that knowledge alone is not enough to participate in
SDM. Two factors (education and immigrant status) that influence a patient’s
empowerment to participate in decision making had a significant relationship with SDM.
Thus, for SDM to occur, patients need to be informed and empowered to participate in
their clinical decision-making process. The provision of knowledge is the relatively easy
piece to accomplish because the patient portal can provide that information however,
hospitals, practices and providers need to make the process of SDM a priority. Patients
cannot fully engage in their decisions except the provider creates an enabling
environment for SDM.
Future research should focus on how to encourage providers and empower
patients to participate in SDM. Perhaps linking provider reimbursement to SDM may
motivate providers to create an enabling environment for their patients to participate in
their clinical decision making. One of such could be providing reimbursement for time
spent communicating with the patient on the EHR portal.
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More research should be done on methods to enable patients feel competent
enough to participate in their care. Even though this study does not show an association
between the portal and SDM, there is the possibility that if the portal is more user
friendly it would enable patients to participate in their care. This study showed that most
patients accessed the portal about once or twice a year. There are basic features required
for all portals, each health IT vendor has a unique outlay of their portal. Further research
should explore the specific features of the patient portal that could promote SDM and
ease of access to the portal. Perhaps, the burden of trying to log into the portal might also
be one of the reasons why the portal is not influencing participation in SDM.
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